<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Oxid Med Cell Longev</journal-id>
<journal-id journal-id-type="iso-abbrev">Oxid Med Cell Longev</journal-id>
<journal-id journal-id-type="publisher-id">OMCL</journal-id>
<journal-title-group>
<journal-title>Oxidative Medicine and Cellular Longevity</journal-title>
</journal-title-group>
<issn pub-type="ppub">1942-0900</issn>
<issn pub-type="epub">1942-0994</issn>
<publisher>
<publisher-name>Hindawi</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31191805</article-id>
<article-id pub-id-type="pmc">6525823</article-id>
<article-id pub-id-type="doi">10.1155/2019/8267234</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-4501-8661</contrib-id>
<name>
<surname>Vona</surname>
<given-names>Rosa</given-names>
</name>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-3899-5958</contrib-id>
<name>
<surname>Gambardella</surname>
<given-names>Lucrezia</given-names>
</name>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cittadini</surname>
<given-names>Camilla</given-names>
</name>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0003-0784-9077</contrib-id>
<name>
<surname>Straface</surname>
<given-names>Elisabetta</given-names>
</name>
<email>elisabetta.straface@iss.it</email>
<xref ref-type="aff" rid="I1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Pietraforte</surname>
<given-names>Donatella</given-names>
</name>
<xref ref-type="aff" rid="I2">
<sup>2</sup>
</xref>
</contrib>
</contrib-group>
<aff id="I1">
<sup>1</sup>Biomarkers Unit, Center for Gender-Specific Medicine, Istituto Superiore di Sanità, Rome, Italy</aff>
<aff id="I2">
<sup>2</sup>Core Facilities, Istituto Superiore di Sanità, Rome, Italy</aff>
<author-notes>
<fn fn-type="other">
<p>Guest Editor: Maurizio Di Mauro</p>
</fn>
</author-notes>
<pub-date pub-type="collection">
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>5</day>
<month>5</month>
<year>2019</year>
</pub-date>
<volume>2019</volume>
<elocation-id>8267234</elocation-id>
<history>
<date date-type="received">
<day>25</day>
<month>9</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>8</day>
<month>2</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>3</month>
<year>2019</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2019 Rosa Vona et al.</copyright-statement>
<copyright-year>2019</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<abstract>
<p>Metabolic syndrome (MS) represents worldwide public health issue characterized by a set of cardiovascular risk factors including obesity, diabetes, dyslipidemia, hypertension, and impaired glucose tolerance. The link between the MS and the associated diseases is represented by oxidative stress (OS) and by the intracellular redox imbalance, both caused by the persistence of chronic inflammatory conditions that characterize MS. The increase in oxidizing species formation in MS has been accepted as a major underlying mechanism for mitochondrial dysfunction, accumulation of protein and lipid oxidation products, and impairment of the antioxidant systems. These oxidative modifications are recognized as relevant OS biomarkers potentially able to (i) clarify the role of reactive oxygen and nitrogen species in the etiology of the MS, (ii) contribute to the diagnosis/evaluation of the disease's severity, and (iii) evaluate the utility of possible therapeutic strategies based on natural antioxidants. The antioxidant therapies indeed could be able to (i) counteract systemic as well as mitochondrial-derived OS, (ii) enhance the endogenous antioxidant defenses, (iii) alleviate MS symptoms, and (iv) prevent the complications linked to MS-derived cardiovascular diseases. The focus of this review is to summarize the current knowledge about the role of OS in the development of metabolic alterations characterizing MS, with particular regard to the occurrence of OS-correlated biomarkers, as well as to the use of therapeutic strategies based on natural antioxidants.</p>
</abstract>
<funding-group>
<award-group>
<funding-source>Ministry of Health</funding-source>
<award-id>RF-2013-02358715</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
<body>
<sec id="sec1">
<title>1. Introduction</title>
<p>Metabolic syndrome (MS) represents worldwide public health issue. It is characterized by a group of metabolic risk factors in the same person. The key factors are obesity, measured by waist circumference and body mass index (BMI), dyslipidemia, increased blood pressure, hyperglycemia, and insulin resistance [<xref ref-type="bibr" rid="B1">1</xref>].</p>
<p>A persistent increase of MS is a risk factor for type 2 diabetes (T2D), cardiovascular diseases (CVD), and premature mortality [<xref ref-type="bibr" rid="B1">1</xref>].</p>
<p>The pathogenesis of MS is very complex and not yet clear. Several studies support the concept that oxidant/antioxidant imbalance may play an important role in its manifestations [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>].</p>
<p>Increased biomarkers of oxidative stress (OS) and decreased antioxidant defenses have been measured in blood of patients with MS suggesting an <italic>in vivo</italic> overproduction of oxidizing species [<xref ref-type="bibr" rid="B1">1</xref>–<xref ref-type="bibr" rid="B6">6</xref>]. In particular, it has been reported that patients with MS have decreased antioxidant protection, in the form of depressed serum vitamin C and <italic>α</italic>-tocopherol concentrations, decreased superoxide dismutase (SOD) activity, and increased protein and lipid oxidation levels [<xref ref-type="bibr" rid="B1">1</xref>–<xref ref-type="bibr" rid="B6">6</xref>].</p>
<p>Many studies are focused on preventing OS in MS. Recent literature data suggest that diets that are rich in whole grain cereals, fruits, and vegetables, with low animal fat consumption, can ameliorate OS status [<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>].</p>
<p>This review is aimed at presenting an overview on the role of OS in the pathogenesis of MS and the related diseases. In particular, it is focused on (i) mitochondrial redox state and dysfunction, (ii) most reported and validated biomarkers of stress in metabolic disease manifestations, and (iii) benefit of various nutritional antioxidants. In addition, the role of “gut microbiota” in MS will be described.</p>
</sec>
<sec id="sec2">
<title>2. Oxidative Stress: An Overview</title>
<p>OS results from unbalanced production of reactive oxygen and nitrogen species (ROS and RNS, respectively) associated with decreased amount/expression and impaired activity of antioxidant systems. When available in appropriate low amounts, ROS and RNS act as signal transduction molecules driving cell activities and providing cell protection [<xref ref-type="bibr" rid="B9">9</xref>]. On the other hand, when produced in excess, as in the case of inflamed tissues, they can generate further highly reactive species able to oxidize irreversibly proteins, lipids, and nucleic acids. Very important is the oxidative modification of critical enzymes or regulatory sites, whose redox modification triggers cell signaling alteration and programmed cell death [<xref ref-type="bibr" rid="B9">9</xref>].</p>
<sec id="sec2.1">
<title>2.1. ROS and RNS in Physiology and Pathophysiology</title>
<p>A suitable equilibrium between ROS and RNS generation and antioxidant levels allows, without any sort of damage, either the cross talk between cells or the control of fundamental intracellular functions, such as cell-cell interactions, proliferation, differentiation, migration, and contraction. These activities are carried out through the direct or indirect reversible-redox modification of critical targets located within catalytic enzymes or regulatory sites [<xref ref-type="bibr" rid="B9">9</xref>]. These targets include iron-sulfur clusters, metals, flavin and nicotinamide cofactors, and quinones. The most relevant physiological targets are protein thiol/disulfides, with particular regard to those present within catalytic enzymes or regulatory sites, as well as in receptors, channels and transporters, transcription factors, kinases, and phosphatases. The reversible thiol oxidation products include sulfenic acid (sulfenylation) and the adducts with <sup>•</sup>NO-derived species (S-nitrosylation), glutathione (S-glutathionylation), and H<sub>2</sub>S (S-sulfhydration). These oxidative modifications represent the finest regulation of redox-based signaling affecting protein activity, protein–protein interactions, and protein location, inducing conformational and functional changes of fundamental target macromolecules involved in redox signaling. A slight imbalance by oxidant formation can be counteracted by a performance activity of the antioxidant system, which allows cells to return to their physiological status. In pathological condition, such as inflammation, atherosclerosis, ischemia/reperfusion injury, and diabetes mellitus, the oxidant-generating enzymes in tissues are activated to produce higher amounts of ROS and RNS at nonphysiological locations. These amounts, in association with the impaired activity of the antioxidant systems, lead to the irreversible oxidation of proteins, lipids, and nucleic acids [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>]. This unbalanced redox equilibrium, called OS, triggers cell signaling alteration leading to loss of essential cellular functions, senescence, and programmed cell death [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>].</p>
</sec>
<sec id="sec2.2">
<title>2.2. Sources of ROS and RNS</title>
<p>ROS and RNS are chemical heterogeneous molecules that include radical species, such as superoxide anion (O<sub>2</sub><sup><underline>•</underline></sup>), hydroxyl radicals (<sup>•</sup>OH) and nitric oxide (<sup>•</sup>NO), and nonradical species, such as hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>), hypochlorous acid (HClO), and peroxynitrite (ONOO-). They are continuously produced within the cells particularly as (i) the result of the electron transfer processes in the mitochondria and (ii) the activity of several inflammation-linked enzymes, such as NADPH oxidase, nitric oxide synthase (NOS), xanthine oxidase, myeloperoxidase (MPO), lipoxygenase (LOX), and cyclooxygenase (COX) [<xref ref-type="bibr" rid="B9">9</xref>]. Interestingly, O<sub>2</sub><sup><underline>•</underline></sup> and <sup>•</sup>NO are poor oxidizing molecules, with behavior linked to their chemical structure and their thermodynamic properties. These characteristics are expressed by the standard one-electron reduction potential, a parameter suitable to predicting the hierarchy of radical reactivity in terms of ability to transfer the unpaired electron to any oxidized species [<xref ref-type="bibr" rid="B11">11</xref>]. The values range from positive one-electron reduction potential (highly oxidizing species) to negative one-electron reduction potential (highly reducing species) [<xref ref-type="bibr" rid="B11">11</xref>]. The one-electron reduction potential of O<sub>2</sub><sup><underline>•</underline></sup> is 0.94 V [<xref ref-type="bibr" rid="B11">11</xref>], while the one of <sup>•</sup>NO is -0.80 V [<xref ref-type="bibr" rid="B12">12</xref>]. These values are by far lower than the ones taken for the most reactive unspecific <sup>•</sup>OH (2.3 V) and confer to O<sub>2</sub><sup><underline>•</underline></sup> a low reactivity and to <sup>•</sup>NO to be almost unreactive with most of the biological molecules. Notwithstanding their poor oxidizing potential, O<sub>2</sub><sup><underline>•</underline></sup> and <sup>•</sup>NO represent the central nucleus of cellular oxidative chemistry, because they both directly and indirectly control the intracellular redox-based signaling and are the precursors of the most important oxidizing species produced under pathological conditions. Compared to many free radicals, O<sub>2</sub><sup><underline>•</underline></sup> has a relatively long half-life that permits diffusion inside the cell where it can be converted to H<sub>2</sub>O<sub>2</sub> by the action of SOD. At low concentrations, H<sub>2</sub>O<sub>2</sub> diffuses in intracellular compartments and reacts with specific protein residues, such as cysteine, methionine, and selenocysteine, assuming a key role in the regulation of the intracellular redox signaling [<xref ref-type="bibr" rid="B9">9</xref>]. At higher concentrations and in the presence of transition metals, H<sub>2</sub>O<sub>2</sub> generates however the strong oxidant <sup>•</sup>OH, which randomly reacts with all the most important macromolecules, inducing lipid peroxidation and oxidation of protein, DNA, and carbohydrates, leading to impairment of their activity and functions. <sup>•</sup>NO is generated via enzymatic reaction catalyzed by the different isoforms of NOS. Moreover, <sup>•</sup>NO can regulate intracellular signaling by directly inducing posttranscriptional reversible modification of cysteine residues in proteins, i.e., s-nitrosylation. On the other hand, the activation of intracellular pathways leading to ROS formation allows <sup>•</sup>NO to rapidly react with O<sub>2</sub><sup>•</sup> and to produce the strong oxidant ONOO<sup>−</sup> [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B13">13</xref>]. The oxidative chemistry mediated by ONOO<sup>−</sup> is led by its direct reactivity with several cellular targets (including CO<sub>2</sub>, hemoproteins, DNA, lipids, and protein residues such as thiols, tyrosine, tryptophan, and methionine) or indirect- CO<sub>2</sub>-dependent oxidations mediated by strong oxidizing radicals, such as <sup>•</sup>NO<sub>2</sub> (nitrogen dioxide radical) and carbonate radical (CO<sub>3</sub><sup><bold>•</bold></sup>). Importantly, with the further increase of NOS activity such as that characterizing inflammatory conditions, <sup>•</sup>NO<sub>2</sub> rapidly reacts with <sup>•</sup>NO forming dinitrogen trioxide (N<sub>2</sub>O<sub>3</sub>), which in turn mediates nitrosylation of target compounds, such as thiols. Interestingly, under inflammatory conditions the increased OS in tissues can lead to the consumption of substrates or to the oxidation of cofactors, in the specific case of (6R)-5,6,7,8-tetrahydro-L-biopterin essential for the correct NOS activity promoting O<sub>2</sub><sup>•</sup> instead of <sup>•</sup>NO formation, referred to as endothelial NOS (eNOS) uncoupling. This condition increases further OS and decreases <sup>•</sup>NO bioavailability leading to hypertension and vascular dysfunction in animal models of obesity, increasing further the risk of CVD diseases [<xref ref-type="bibr" rid="B13">13</xref>–<xref ref-type="bibr" rid="B15">15</xref>].</p>
<p>The prooxidant heme-containing MPO is released by activated neutrophils and monocytes/macrophages in tissues where it catalyzes the conversion of H<sub>2</sub>O<sub>2</sub> to hypohalous acids (HOX; X=Cl, Br, and SCN) in the presence of halide and pseudo-halide ions [<xref ref-type="bibr" rid="B16">16</xref>]. The major reactive species produced by MPO under physiological conditions are hypochlorous acid (HOCl), hypothiocyanous acid (HOSCN), and species with nitrating activity in the presence of NO<sub>2</sub><sup>−</sup> and H<sub>2</sub>O<sub>2</sub>. These species are key contributors to the physiological microbicidal activity of phagocytes. However, excessive generation of MPO-derived oxidants has been linked to tissue damage in many diseases, especially in those characterized by acute or chronic inflammation [<xref ref-type="bibr" rid="B17">17</xref>].</p>
<sec id="sec2.2.1">
<title>2.2.1. Mitochondrial Functions and OS</title>
<p>Mitochondria are crucial, multifunctional organelles, which actively regulate cellular homeostasis. Their main function is to produce energy as adenosine triphosphate (ATP) via citric cycle (tricarboxylic acid cycle, Krebs cycle). Other cell functions include ionic homeostasis, production and regulation of ROS, lipid and carbohydrate utilization, pH regulation, steroid hormone synthesis, calcium homeostasis, thermogenesis, and cell death [<xref ref-type="bibr" rid="B18">18</xref>–<xref ref-type="bibr" rid="B20">20</xref>].</p>
<p>As mentioned before, mitochondria are the primary intracellular site of oxygen consumption and the major source of ROS, most of them originating from the mitochondrial respiratory chain. Dysfunction of the respiratory chain may lower the ATP production, increase ROS production, reduce antioxidative capacity, and induce apoptosis. ROS, highly reactive molecules radicals, and nonradicals have the ability to capture electrons from molecules (proteins and nucleic acids) with whom they get in contact, leading to cell damage. In healthy cells, an intricate homeostatic system regulates and maintains optimal mitochondrial function. A failure of this system is observed in obesity, asthma, and metabolic syndrome progression [<xref ref-type="bibr" rid="B21">21</xref>]. Mitochondrial dysfunction, characterized by proapoptotic Bax and Bcl-xS proteins, reduces the expression of the antiapoptotic protein Bcl-xL and cytochrome C release and partially activates caspase cascade, high protein carbonyl content, and 8-hydroxy-2¢-deoxyguanosine. Growing evidence suggests that these dysfunctions have a strong relationship with various MS components, resulting in clinical complications [<xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B23">23</xref>]. Cheng and Almeida declare that mitochondrial dysfunction is an early pathophysiological event in insulin resistance and obesity development [<xref ref-type="bibr" rid="B24">24</xref>]. Mitochondrial dysfunction leads to the activation of stress pathways, which reduce cellular sensitivity to insulin, limiting nutrient influxes and preventing further damages. Chronically, in organs such as liver and skeletal muscle, it appears as reduced mitochondrial metabolism and insulin resistance, following consequent hyperinsulinemia and different nutrient storages in adipose tissue [<xref ref-type="bibr" rid="B25">25</xref>–<xref ref-type="bibr" rid="B27">27</xref>]. In addition to this, in epithelial and vascular endothelial cells, mitochondrial dysfunction interferes with •NO synthesis leading to oxide/nitrate stress.</p>
<p>Several studies demonstrate that in different tissues, mitochondria adapt physically to nutrient availability and that obesity causes mitochondrial OS and dysfunction [<xref ref-type="bibr" rid="B28">28</xref>, <xref ref-type="bibr" rid="B29">29</xref>]. O'Keefe and Bell proved that, apparently, high caloric intake raises plasma free fatty acid (FFA) and glucose levels, which are closely associated with high ROS generation and obesity exacerbation [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B30">30</xref>]. Conversely, calorie restriction alleviates sarcopenia [<xref ref-type="bibr" rid="B31">31</xref>].</p>
<p>In cardiomyocytes of young patients, an excess of body weight impairs mitochondrial function also in the absence of heart failure and diabetes [<xref ref-type="bibr" rid="B32">32</xref>]. Moreover, in humans and mouse models, obesity results in mitochondrial dysfunction, skeletal muscle, and adipose tissue [<xref ref-type="bibr" rid="B33">33</xref>].</p>
<p>Mitochondria are subject to dynamic processes in order to establish a control system related to survival or cell death and adaptation to changes in the metabolic environment of cells. The mitochondrial dynamic includes several processes such as fusion and fission, biogenesis, and mitophagy. Modifications of the mitochondrial dynamic in organs involved in energy metabolism such as the pancreas, liver, skeletal muscle, and white adipose tissue could be of relevance for the development of insulin resistance, obesity, and type 2 diabetes. Metabolic status can condition the number, form, and function of mitochondria, influencing organ function. Conversely, changes in mitochondrial dynamic influence organ metabolism. Mitochondrial biogenesis is critical for the normal function of cells, and it can be produced in response to an oxidative stimulus. Mitochondrial fusion is linked to increased ATP production, while the inhibition of this process is associated with ROS production [<xref ref-type="bibr" rid="B34">34</xref>–<xref ref-type="bibr" rid="B36">36</xref>].</p>
</sec>
</sec>
<sec id="sec2.3">
<title>2.3. Detection of ROS and RNS in the Biological System</title>
<p>To characterize ROS/RNS and to understand their role in the mechanisms leading to the different pathological conditions and diseases, the specific detection and quantification of the oxidants produced are fundamental. Luminescence-based techniques, such as fluorescence, chemiluminescence, and bioluminescence, have been applied to biological systems (cell-free systems, <italic>in vitro</italic> cell cultures, and <italic>in vivo</italic> animal models) to detect directly cellular oxidizing species, such as O<sub>2</sub><sup>•</sup>, H<sub>2</sub>O<sub>2</sub>, <sup>•</sup>NO, and ONOO<sup>−</sup>. These methods rely to the use of specific probes, such as dihydrorhodamine, dihydroethidium, dihydrodichlorofluorescein, Amplex Red, and boronates. All of these are able to interact with the formed oxidants and to provide information about the different species produced in the studied system. Initially, these methods have been used to study the changes of the redox environment in cell systems. Subsequently, with increasing knowledge on chemical reactivity and suitable/useless end product formation, several limitations on the use of these probes have been proved [<xref ref-type="bibr" rid="B37">37</xref>–<xref ref-type="bibr" rid="B39">39</xref>]. These limitations deal with the chemical features of the probes as well as their reactivity, such as (i) secondary chemical interactions between probe end products, the probe-derived radicals, and the oxidants generated in the studied system; (ii) redox cycling and generation of ROS by probes and their oxidation products; (iii) probe interaction with metals and with the intracellular antioxidants; (iv) intracellular compartmentalization of probes and sites of oxidant formation; and (v) probe sensitivity to light and pH changes [<xref ref-type="bibr" rid="B37">37</xref>–<xref ref-type="bibr" rid="B39">39</xref>]. Another method suitable for ROS and RNS identification in biological systems is the electron paramagnetic resonance spectroscopy (EPR) that, in combination with the spin trapping technique, allows identifying oxidants such as O<sub>2</sub><sup><underline>•</underline></sup>, <sup>•</sup>OH, and <sup>•</sup>NO. The spin trapping technique permits the species-specific and time-dependent detection of products, showing typical EPR spectral characteristics. The signals obtained from the different formed radicals may be compared to complementary simple control experiments using inhibitors/scavenger/competitor compounds. The main restrictions to the application of the EPR-spin trapping technique are (i) low rate/concentration of oxidant formation in the biological system, (ii) low trapping rate constant of the used probes, and (iii) reduction of the EPR-active spin adduct to EPR silent product(s) by endogenous antioxidants/reducing systems [<xref ref-type="bibr" rid="B40">40</xref>].</p>
<p>Recent literature data on this topic illustrate that the simultaneous use of different techniques, i.e., EPR, HPLC, fluorescence, and LC-MS, is the best way to identify ROS and RNS in biological systems. Each of them provides useful information concurring to identify the formed species by detecting the specific adducts and end products [<xref ref-type="bibr" rid="B38">38</xref>–<xref ref-type="bibr" rid="B40">40</xref>].</p>
</sec>
<sec id="sec2.4">
<title>2.4. Tissue Antioxidant Systems</title>
<p>Cells contain both enzymatic and nonenzymatic antioxidants that work together to regulate ROS and RNS concentrations. The primary antioxidant enzymes in tissues that are able to detoxify directly oxidizing species include SOD, glutathione peroxidase (Gpx), and catalase (CAT), and bilirubin. Other fundamental antioxidant enzymes such as glutathione reductase (GR), peroxiredoxins (Prx), thioredoxin (Trx), thioredoxin reductase (TrxR), and glutaredoxins (Grx) also contribute to cellular protection by reducing oxidized critical thiols in key enzymes/proteins and maintaining the suitable intracellular redox state [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B41">41</xref>]. The nonenzymatic system includes endogenous compounds, such as reduced glutathione (GSH), uric acid, bilirubin, and ceruloplasmin, as well as dietary low-molecular-weight compounds, such as vitamins (vitamins A, C, and E), <italic>β</italic>-carotene, flavonoids, polyphenols, and zinc and selenium. The latter are the key components of enzymes such as Gpx and TrxR [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B41">41</xref>]. SODs are a group of metalloenzymes that can be compartmentalized in different cellular districts, such as cytosol (CuZn-SOD), mitochondria (Mn-SOD), and the extracellular matrix (EC-SOD). The main activity of this enzyme is to catalyze the conversion of O<sub>2</sub><sup>•</sup> to H<sub>2</sub>O<sub>2</sub>.</p>
<p>SODs then contribute to control ROS intracellular concentration and, in conjunction with CAT and GPx, to maintain the flux of H<sub>2</sub>O<sub>2</sub> suitable for redox regulation of intracellular signaling. GPx is an enzyme dependent on the micronutrient selenium and plays a crucial role in the reduction of lipid oxidation and peroxide detoxification. Moreover, together with GR, it plays a critical role in GSH metabolism, reducing glutathione disulfide (GSSG) to GSH, by the NADPH-dependent mechanism. Prxs are thiol-specific antioxidant enzymes that reduce various cellular peroxide substrates, including H<sub>2</sub>O<sub>2</sub> and ONOO-, using cysteine-containing active sites. TrxR and Grx have catalytic-redox-active cysteines and catalyze the reduction of protein mixed disulfides. Trx in particular has function in DNA and protein repair by reducing ribonucleotide reductase as well as methionine sulfoxide reductases.</p>
<p>Some of these antioxidants, proteins, and redox enzymes belong to a network connected through substrates and products. Together with oxidized/reduced glutathione and oxidized/reduced Trx, the redox couple NADP<sup>+</sup>/NADPH is crucial for the intracellular redox homeostasis. Indeed, it provides reducing equivalents for the two main detoxifying enzyme systems (GR/GPx/GSH and TrxR/Trx/Prx) involved in H<sub>2</sub>O<sub>2</sub> removal, in maintaining the suitable thiol/disulfide intracellular equilibrium linked to redox signaling (sulfenic acids, S-nitrosothiols, S-glutathionylation, etc.) [<xref ref-type="bibr" rid="B9">9</xref>]. NADP<sup>+</sup>/NADPH and the redox enzymes also have a key role in controlling smooth muscle vascular relaxation through the regulation of the intracellular calcium concentration from the potassium channels, the sarco(endo)plasmic reticulum calcium ATPase (SERCA) pump, ion channels controlling membrane potential, and contractile-enhancing systems [<xref ref-type="bibr" rid="B42">42</xref>]. The main source of intracellular NADPH is the oxidative branch of the pentose phosphate pathway, with the cofactor being produced by the rate-limiting glucose-6-phosphate dehydrogenase and 6-phosphogluconate dehydrogenase. Other sources of NADPH are the cytoplasmatic and mitochondrial isoforms of isocitrate dehydrogenases, formyltetrahydrofolate dehydrogenases, methylenetetrahydrofolate reductase, and the NADP-dependent malic enzymes [<xref ref-type="bibr" rid="B43">43</xref>].</p>
<p>Low-molecular-weight compounds are fundamental antioxidant molecules because they can directly detoxify ROS and RNS and repair oxidized biological targets [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B41">41</xref>]. GSH is the predominant non-protein low-molecular-weight compound (0.5–10 mM) in animal cells and is the major cellular redox buffer, so that its concentration and the one GSSG are commonly used to calculate the GSH/GSSG ratio, universally used as an indicator of the cellular redox environment [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B11">11</xref>, <xref ref-type="bibr" rid="B23">23</xref>]. GSH reacts with several oxidizing species, including <sup>•</sup>OH, HClO, and ONOO<sup>−</sup>, and is the substrate of GPx in its peroxide detoxification activity.</p>
<p>Vitamin C or ascorbic acid, the first antioxidant defense in tissues, is a biologically ubiquitous and water-soluble antioxidant able to donate an electron to potentially damaging oxidizing radicals such as <sup>•</sup>OH, alkoxyl radical (RO<sup>•</sup>), peroxyl radical (ROO<sup>•</sup>), thiyl radical (GS•), and tocopheroxyl radicals (TO<sup>•</sup>). It has been shown that physiological concentrations of ascorbic acid inhibit oxidation of LDL, lipid, and protein. An important feature of ascorbic acid is acting synergistically with vitamin E and protecting this vitamin from the oxidative modifications. Vitamin E is indeed lipid-soluble, it is the primary antioxidant in LDL and lipid membrane, and its one-electron oxidation product, the <italic>α</italic>-tocoperoxyl radical, can be reduced by ascorbic acid. There are eight naturally occurring vitamin E isoforms, namely, <italic>α</italic>-, <italic>β</italic>-, <italic>γ</italic>-, and <italic>δ</italic>-tocopherol and <italic>α</italic>-, <italic>β</italic>-, <italic>γ</italic>-, and <italic>δ</italic>-tocotrienol. <italic>α</italic>-Tocopherol acts as a radical-scavenging antioxidant against lipid peroxidation by scavenging lipid-centered ROO<sup><bold>•</bold></sup> before it attacks lipid in other molecules to yield lipid hydroperoxide (LOOH), and a lipid radical (L<sup>•</sup>), which propagates the chain oxidation. <italic>β</italic>-Carotene is a powerful singlet oxygen quencher and exhibits additional, strong antioxidant properties. It is very reactive to peroxyl radicals and DNA damage, but less so to <sup>•</sup>OH and O<sub>2</sub><sup><underline>•</underline></sup>.</p>
<p>Uric acid is synthesized mainly in the liver, intestines, and the vascular endothelium as the end product of an exogenous pool of purines, is a strong ROS and RNS scavenger (such as <sup>•</sup>OH, ONOO<sup>−</sup>, and HClO), and has metal-chelating properties in blood plasma as in saliva.</p>
<p>Bilirubin has been proved to be a powerful antioxidant in human blood plasma both in its unconjugated form and complexed with serum albumin. In addition to its ability to inhibit membrane lipid peroxidation acting in synergy with the membrane-bound <italic>α</italic>-tocopherol, bilirubin can scavenge both ROS and RNS and protect proteins from ROS- and RNS-mediated oxidative damage [<xref ref-type="bibr" rid="B41">41</xref>]. Prooxidant and antioxidant systems are shown in <xref ref-type="fig" rid="fig1">Figure 1</xref>.</p>
</sec>
<sec id="sec2.5">
<title>2.5. Biomarkers of OS Damage</title>
<p>In addition to the indirect measurement of ROS and RNS levels, oxidized molecules reflect the damage mediated by OS in cells and tissues, and their measurement can be indicative for the occurrence of OS in a specific disease, as well as the potential efficacy of clinical treatments.</p>
<p>As already mentioned, ROS and RNS generically can react with all the macromolecules of biological importance in cell and tissues, generating oxidative modification in lipids, DNA, and proteins that, in some cases, can be the footprint of the oxidant generated [<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B45">45</xref>].</p>
<p>Most of these oxidized molecules can be measured in plasma by using ELISA kits or by HPLC.</p>
<p>Polyunsaturated fatty acids (PUFAs), in particular linoleic and arachidonic acid, are important targets of lipid peroxidation. Malondialdehyde (MDA) and 4-hydroxy-2-nonenal (HNE) are the most investigated end products of lipid oxidation. MDA is one of several low-molecular-weight end products formed via the decomposition of certain primary and secondary lipid peroxidation products. It is a specific marker of omega-3 and omega-6 fatty acid peroxidation [<xref ref-type="bibr" rid="B46">46</xref>]. 4-HNE is an <italic>α</italic>, <italic>β</italic>-unsaturated aldehyde that derives from the oxidation of essentially arachidonic and linoleic acid, which are the two most represented fatty acids in biomembranes [<xref ref-type="bibr" rid="B47">47</xref>]. It is toxic at high concentrations (from 1 <italic>μ</italic>M to 10 <italic>μ</italic>M), while it plays a role in signaling activities at lower concentrations (under 1 <italic>μ</italic>M) [<xref ref-type="bibr" rid="B47">47</xref>].</p>
<p>ROS and RNS generate a large number of oxidative modifications in DNA including nucleotide oxidation, strand breakage, loss of bases, and adduct formation. The <sup>•</sup>OH radical can react with all purine and pyrimidine bases, as well as deoxyribose backbone, generating various products, the most common one being 7,8-dihydroxy-8-oxo-24′-deoxyguanosine (8oxodG), which can be assessed noninvasively in the urine [<xref ref-type="bibr" rid="B48">48</xref>–<xref ref-type="bibr" rid="B49">49</xref>].</p>
<p>The main cellular targets of ROS and RNS in tissues are doubtless the highly concentrated proteins, which undergo posttranscriptional oxidative modifications (oxidation, carbonylation, nitrosylation, and nitration) of specific amino acid residues (cysteine, aromatic amino acids, histidine, and methionine). Some of these modifications are reversible (i.e., some oxidation products and nitrosylation of thiol groups), while others are irreversible (carbonylation and nitration) and can lead to the alteration of protein expression and activity. The reversible oxidative modifications are involved in the physiologic redox regulation of cellular signaling and are involved in particular cysteine in specific proteins or enzymes. Cysteine oxidation usually starts with the formation of sulfenic acid (-SOH), disulfide bridges (S-S-), S-glutathionylation (protein-SSG), and S-nitrosylation (-SNO) [<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B50">50</xref>]. The reversibility is linked to the activity of low-molecular-weight antioxidants, such as GSH and vitamin C, as well as the activity of antioxidant enzyme, such as GR, Grx, Trx/TrdR, and Prdx. Protein S-nitrosylation (addiction of -NO group) can be induced by RNS, such as <sup>•</sup>NO, nitroxyl, and ONOO<sup>−</sup>. This thiol modification, and its reversibility, plays a pivotal role in cell physiology and signaling, so that S-nitrosylation has been regarded as functionally equivalent to protein phosphorylation and dephosphorylation [<xref ref-type="bibr" rid="B50">50</xref>].</p>
<p>The irreversible oxidative protein modification can allow to the definitive alteration of protein expression and activity, which inevitably reflects on cellular trafficking and redox signaling. This is particular true for cysteine residues in specific proteins or enzymes in which the oxidation processes, going further sulfenic acid formation, proceeds with the formation of sulfinic (-SOOH) and sulfonic (-SOOOH) acids, leading to the irreversible inactivation of their activity [<xref ref-type="bibr" rid="B9">9</xref>]. The carbonyl groups can be generated after the attack of the <sup>•</sup>OH radical against the residues of proline, lysine, and arginine [<xref ref-type="bibr" rid="B51">51</xref>–<xref ref-type="bibr" rid="B53">53</xref>]. Carbamylated proteins are interesting to use as biomarkers, because they may quantitatively reflect the burden of pathological conditions (inflammation and uremia) and are present in plasma or whole blood. Finally, protein tyrosine residues can undergo nitration reaction (addiction of -NO<sub>2</sub> group) to form 3-nitrotyrosine and can be generated through several pathways including their selective reaction with ONOO- and the derived strong oxidants, such as <sup>•</sup>OH, <sup>•</sup>CO<sub>3</sub>, and NO<sub>2</sub><sup>•</sup>, with nitrite anion at acidic pH, or with activated peroxidases in the presence of nitrite anion [<xref ref-type="bibr" rid="B52">52</xref>]. Protein nitration induces a loss and gain of protein function, compete with protein phosphorylation, stimulate the autoimmune response, and affect protein turnover. Biomarkers of OS are shown in <xref ref-type="table" rid="tab1">Table 1</xref>.</p>
</sec>
</sec>
<sec id="sec3">
<title>3. Oxidative Stress in Diabetes and Metabolic Syndrome: State of the Art</title>
<p>Elevated OS in individual with T2D and MS has been shown to be one of the major risk factors for an increased risk of cardiovascular disease [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B53">53</xref>]. T2D is a metabolic disease associated with increased formation of ROS and RNS, as well as decreased antioxidant potential [<xref ref-type="bibr" rid="B54">54</xref>]. The precise mechanism by which OS may accelerate the development of complications in diabetes is partly known [<xref ref-type="bibr" rid="B1">1</xref>]. T2D is characterized by chronically elevated blood glucose levels, which may be caused by increased insulin resistance and glucose intolerance. Persistent hyperglycemia in T2D causes nonenzymatic protein glycation and oxidative degeneration. In the early stage of protein glycation, the aldehyde group of sugar reacts with amino acids to produce Schiff's base, which undergoes a series of modifications to form Amadori rearrangement products [<xref ref-type="bibr" rid="B55">55</xref>]. The accumulation of advanced glycation end products (AGE) contributes to diabetic complications through direct tissue damage and activation of specific AGE receptors (RAGE) [<xref ref-type="bibr" rid="B56">56</xref>]. AGEs and RAGE interaction elicit OS generation in various types of cells and subsequently evoke proliferative, inflammatory, and thrombogenic reactions, playing an important role in the development and progression of diabetes-associated disorders [<xref ref-type="bibr" rid="B57">57</xref>]. Biomarkers of protein glycation in T2D are glycated hemoglobin (HbA1c) and glycated low-density lipoprotein (gl-LDL). HbA1c is more negatively charged than hemoglobin and has a higher oxygen affinity therefore reducing gaseous exchange to tissues. Glycated LDL loses its affinity for the LDL receptor, but it is not very inflammatory. Biomarker of oxidative degeneration in T2D is an oxidized low-density lipoprotein (ox-LDL) that, in contrast to gl-LDL, is a proinflammatory and proatherogenic particle containing protein adducts and inflammatory lipids that promote atherosclerosis. Studies have shown that ox-LDL within the vascular endothelium leads to the expression of monocyte chemoattractant protein-1 (MCP-1), known to promote vascular endothelial dysfunction and to increase thrombogenicity [<xref ref-type="bibr" rid="B58">58</xref>]. Increased amounts of ox-LDL, carbonylation of cellular proteins, and NADPH oxidase activity can occur in MS leading to enhance ROS formation, which indicates increased risk of atherosclerosis and myocardial infarction as well as increased OS in MS patients [<xref ref-type="bibr" rid="B58">58</xref>, <xref ref-type="bibr" rid="B59">59</xref>]. Vascular endothelial dysfunction results in increased ROS production and decreased bioavailability of <sup>•</sup>NO due to the formation of ONOO<sup>−</sup>-derived species with oxidizing/nitrating activity. Moreover, ONOO<sup>−</sup> has been reported to inactivate prostacyclin synthase leading to the accumulation of inflammatory and prothrombotic eicosanoids [<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B61">61</xref>]. Finally, in endothelial cells, both gl-LDL and ox-LDL drive mitochondrial dysfunction and high levels of ROS production, especially of O<sub>2</sub><sup><underline>•</underline></sup> [<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B63">63</xref>].</p>
<p>MS, characterized by impaired glucose metabolism, dyslipidemia hypertension, and abdominal obesity, is frequently associated with T2D. As for diabetes, OS plays a pivotal role in the pathogenesis of the MS and in the progression of its complications. In MS, ROS production could be increased by an accumulation of plasma FFAs [<xref ref-type="bibr" rid="B64">64</xref>] that increases ROS and RNS formation and release in endothelial and vascular smooth muscle cells [<xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B65">65</xref>]. FFAs constitute a trigger for ROS increase in adipose tissue, by stimulating NOX and lowering the activity of the antioxidant enzymes [<xref ref-type="bibr" rid="B5">5</xref>]. The exposure of adipose tissues to OS results in the development of systemic inflammatory state, which contributes to obesity-associated vasculopathy and cardiovascular risk [<xref ref-type="bibr" rid="B66">66</xref>].</p>
<p>Currently, hypertension is considered a primary risk factor for MS linked to the decreased <sup>•</sup>NO bioavailability and/or to the FFA-mediated ROS increase in blood plasma. This link has been investigated in animal models of hypertension, in which ROS production, endothelial dysfunction, and lipid peroxidation markers have been found increased as a consequence of fructose administration [<xref ref-type="bibr" rid="B1">1</xref>]. The role of OS in hypertension has been proved also by the positive effects on ROS production and blood pressure measured after the antioxidant administration in animal models of hypertension.</p>
<p>A number of studies, in human's as well as in animal's models, have stated that most diseases associated with MS, such as obesity, insulin resistance, hypertension, dyslipidemia, and diabetes, cause mitochondrial OS, altered mitochondrial morphology, and oxidative phosphorylation functions, as well as the activation of mechanisms leading to the induction of mitophagy and apoptosis (<xref ref-type="fig" rid="fig2">Figure 2</xref>) [<xref ref-type="bibr" rid="B1">1</xref>]. In particular, the accumulation of free cholesterol, ox-LDL, and glycated HDL has been reported to mediate endothelial dysfunction through the ROS-mediated impairment of mitochondrial functions and adipocytokines release boosting the atherogenic processes [<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B67">67</xref>–<xref ref-type="bibr" rid="B70">70</xref>]. Increased protein carbonyls and lipid peroxidation markers together with decreased activities of mitochondrial antioxidant enzymes (SOD and Gpx) have been measured in adipose tissues from obese patients [<xref ref-type="bibr" rid="B71">71</xref>].</p>
<p>Furthermore, the MS-linked pathological conditions, as mentioned before, have been reported to be linked to chronic inflammation mediated by hyperglycemia, FFA and AGE accumulation, and systemic insulin resistance [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B72">72</xref>]. Several proinflammatory mediators, known to promote OS, are released in the vasculature where they boost endothelial activation and dysfunction, causing morbidity and mortality in a large number of MS patients. Among these mediators, inflammatory cytokines (leptin, tumor necrosis factor, and interleukin-6) [<xref ref-type="bibr" rid="B73">73</xref>] and high amounts of glucose [<xref ref-type="bibr" rid="B74">74</xref>] and FFAs [<xref ref-type="bibr" rid="B75">75</xref>] have been recognized to play a pivotal role in the deregulation of the activity of ROS- and RNS-producing systems, such as NADPH oxidases, NOS, and mitochondrial oxidases [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B76">76</xref>].</p>
<p>The following paragraphs will analyze in detail the contribution of each oxidant source to OS occurrence in MS.</p>
<sec id="sec3.1">
<title>3.1. NADPH Oxidases in MS</title>
<p>NADPH oxidases are multi-subunit enzymes present in seven isoforms, called NOX 1–5, and dual oxidase DUOX proteins 1–2 [<xref ref-type="bibr" rid="B76">76</xref>]. These enzymes are expressed in a wide variety of cell types, including endothelial cells and vascular smooth muscle cells, in which the isoforms NOX2/NOX4 and Nox1/NOX4, respectively, are mainly expressed [<xref ref-type="bibr" rid="B76">76</xref>].</p>
<p>The increase in NOXs mediated by O<sub>2</sub><sup>•</sup> production has been detected in several MS-related diseases [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B71">71</xref>, <xref ref-type="bibr" rid="B76">76</xref>, <xref ref-type="bibr" rid="B77">77</xref>]. In an animal model of mice overexpressing one of the NOX subunits (p22phox), an increase in vascular ROS concentration was found. Interestingly, in this study it was observed that a nutrition with a high-fat regimen induced the occurrence of inflammatory status and adipogenesis favoring obesity and MS phenotype appearance [<xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B79">79</xref>]. Moreover, it has been found that FFAs and hyperglycemia promote protein kinase C activation. The activation of this protein is involved in OS-mediated endothelial dysfunction by promoting NOX phosphorylation [<xref ref-type="bibr" rid="B77">77</xref>, <xref ref-type="bibr" rid="B79">79</xref>], by activating mitochondrial oxidases [<xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B80">80</xref>] as well as the signaling linked to the MAPK p38-mediated NOX induction through endothelin-1 signaling [<xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B82">82</xref>]. FFAs and glucose accumulation have been shown to enhance in endothelial and vascular smooth muscle cells, kidney cells, and adipose tissue, lowering in addition the antioxidant enzyme activity [<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B83">83</xref>]. Interestingly, in the endothelium of diabetic mice, FFA-mediated increase in O<sub>2</sub><sup>•-</sup> production has been reversed by the specific NOX inhibitor, diphenyleneiodonium [<xref ref-type="bibr" rid="B84">84</xref>].</p>
<p>Hyperglycemia has been found to promote the NOX-dependent increase in ROS formation in vascular smooth muscle cells, endothelial cells, and cardiomyocytes [<xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B85">85</xref>, <xref ref-type="bibr" rid="B86">86</xref>]. High glucose concentration promotes NOX activation through the stimulation of pathways linked to the protein kinase C and the Ca<sup>2+</sup>/calmodulin-dependent protein kinase and/or in the presence of AGE as well as of angiotensin II [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B78">78</xref>, <xref ref-type="bibr" rid="B87">87</xref>].</p>
<p>The angiotensin II-mediated protein kinase C-dependent NOX activation has been reported to induce mitochondrial dysfunction in cardiomyocytes and endothelial cells [<xref ref-type="bibr" rid="B87">87</xref>, <xref ref-type="bibr" rid="B88">88</xref>]. In addition, high glucose can also stimulate ROS production by inducing mitochondrial dysregulation through the alteration of internal membrane potential and the increase in the flux of electron transfer donors (NADH and FADH) into the mitochondrial respiratory chain [<xref ref-type="bibr" rid="B78">78</xref>]. Despite its involvement in hypertension onset, angiotensin II has been found to inhibit the insulin activity by its binding to the angiotensin type 1 receptor [<xref ref-type="bibr" rid="B89">89</xref>], which, in addition to NOX activation, contributes to the occurrence of vascular insulin resistance, endothelial dysfunction, apoptosis, and inflammation. Finally, hyperglycemia could modify cell signaling and antioxidant defense through the activation of the polyol sugar oxidation pathway, which reduces the intracellular amount of NADPH [<xref ref-type="bibr" rid="B90">90</xref>]. This cofactor is indeed essential for the activity of several enzymes (GR and TrxR) fundamental for the maintenance of the suitable intracellular GSH concentration and redox balance [<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>]. In human endothelial cells, AGE, formed by the nonenzymatic reaction of reducing sugars with proteins, lipids, and nucleic acids, promoted NOX activation [<xref ref-type="bibr" rid="B91">91</xref>]. Interestingly, the administration of RAGE to diabetic mice partially counterbalances vascular dilation and inhibits NOX expression, confirming the key role of AGE/RAGE signaling in regulating OS and endothelial dysfunction in diabetes [<xref ref-type="bibr" rid="B92">92</xref>].</p>
</sec>
<sec id="sec3.2">
<title>3.2. NOSs in MS</title>
<p>The major sources of <sup>•</sup>NO in the heart tissue are (i) endothelial NOS (eNOS), mainly expressed in the coronary and cardiac endothelium; (ii) neuronal NOS (nNOS), mainly located in the cardiac myocytes [<xref ref-type="bibr" rid="B93">93</xref>]; and (iii) inducible enzyme isoform (iNOS), expressed in cardiac myocytes or in neutrophils migrated in this tissue under inflammatory conditions [<xref ref-type="bibr" rid="B94">94</xref>]. Among these isoforms, eNOS and iNOS expression was found increased in the heart of diabetic animals [<xref ref-type="bibr" rid="B95">95</xref>]. In agreement, by EPR spectroscopy, other authors in blood measured increased amounts of <sup>•</sup>NO and augmented levels of some <sup>•</sup>NO-derived oxidation products (lipid peroxidation, 3-nitrotyrosine formation, and nitrite and nitrate concentration) [<xref ref-type="bibr" rid="B94">94</xref>]. Notwithstanding the evidences highlighting its activation, in MS-related disease <sup>•</sup>NO biological activities are in general downregulated due to a dysfunction of the radical metabolism and availability. As reported above, the activation of NOXs measured in the MS-related diseases could lead to increased ROS production. These may decrease •NO availability by (i) forming, through the fast direct reaction between <sup>•</sup>NO and O<sub>2</sub><sup>•</sup> and the vasoconstrictor and cytotoxic oxidant ONOO<sup>−</sup>; (ii) eNOS uncoupling, which can produce O<sub>2</sub><sup>•</sup>, instead of <sup>•</sup>NO, under OS-mediated depletion of the enzyme cofactors, such as (6R)-5,6,7,8-tetrahydro-L-biopterin; and (iii) the NF-<italic>κ</italic>B-mediated release of proinflammatory cytokines (IL-6 and TNF-<italic>α</italic>) able to inhibit NOS activity [<xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B94">94</xref>]. This is the case of dyslipidemia, hyperglycemia, insulin resistance, and hypertension, which affect NOS activity through ROS formation increase mediated by several sources (NOXs and xanthine oxidase, dysregulated mitochondria, and uncoupled NOS) activated by FFAs, high glucose, AGE, angiotensin II, etc. Other intracellular pathways have been reported to alter <sup>•</sup>NO formation in MS by upregulating or downregulating the different NOS isoforms. In particular, in the myocardium, the activation of the leptin/STAT3 pathway upregulates the gene for iNOS, while that linked to leptin/JAK2/IRS-1 stimulates the Akt-mediated eNOS activity. A reduction in NOS activity has been found (i) as a consequence of the modification (OGlcNAcylation) of eNOS protein at the Akt site (condition favoring endothelial dysfunction in diabetic vascular complications); (ii) in hyperocholesterolemia, which impaired the signaling linked to soluble guanylate cyclase (the key enzyme of the •NO signaling pathway); (iii) following PKC activation, which results in the reduction of eNOS activity linked to the phosphorylation of Thr495, which contrarily to the phosphorylation at Ser1177 did not increase the enzyme activity; and (iv) following interaction between AGE and their soluble receptor, which in endothelial cells decreases both eNOS expression and activity [<xref ref-type="bibr" rid="B94">94</xref>].</p>
</sec>
<sec id="sec3.3">
<title>3.3. Mitochondrial Oxidases in MS</title>
<p>The mitochondrial respiratory chain, specifically complexes I (NADH dehydrogenase) and III (ubiquinone-cytochrome b-c1), is the main source of intracellular O<sub>2</sub><sup>•</sup>. Hyperglycemia and obesity allowed mitochondrial dysfunction, including ROS formation, impairing physiological respiration and decreased ATP production in the heart of animal models [<xref ref-type="bibr" rid="B96">96</xref>]. Hyperglycemic-linked mitochondrial dysfunction has been linked to the downregulated expression of the peroxisome proliferator-activated receptor gamma coactivator 1a (PGC-1a), a key factor for mitochondrial metabolism involved in oxidative phosphorylation [<xref ref-type="bibr" rid="B97">97</xref>]. FFAs, such as ox-LDL, can be the cause of mitochondrial dysfunction and/or apoptosis by impairing oxidative phosphorylation and ROS production in vascular endothelial cells and in cardiomyocytes [<xref ref-type="bibr" rid="B98">98</xref>, <xref ref-type="bibr" rid="B99">99</xref>]. AGE and protein kinase C induce mitochondrial ROS formation in through NOX activation [<xref ref-type="bibr" rid="B76">76</xref>, <xref ref-type="bibr" rid="B99">99</xref>, <xref ref-type="bibr" rid="B100">100</xref>].</p>
</sec>
<sec id="sec3.4">
<title>3.4. Red Blood Cells as Potential ROS and RNS Sources in MS</title>
<p>In addition to the biomarkers listed above, there are experimental studies that suggest red blood cells (RBCs) as possible gender-associated biomarkers implicated in the progression of MS [<xref ref-type="bibr" rid="B101">101</xref>].</p>
<p>RBCs, under physiological conditions, exert a scavenging activity towards reactive oxygen and nitrogen species often overproduced in morbidity states, for example, in inflamed tissues. Their deformability is an important prerequisite for vascular “antioxidant” functions. Conversely, under conditions of systemic OS, RBCs have an altered redox state and consequently a loss of their structural and functional characteristics, becoming in turn a source of reactive species and contributing to vascular damage.</p>
<p>A significant increase in RBCs displaying morphological alterations has been detected in patients with MS. In particular, differences in terms of cell aging, cell adhesion, and/or aggregation have been found. These data are in line with other literature data indicating erythrocytes as possible biomarkers of vascular disease [<xref ref-type="bibr" rid="B102">102</xref>].</p>
<p>Possible implications of OS in the integrity and function of RBCs have been also found in patients with non-insulin-dependent diabetes [<xref ref-type="bibr" rid="B103">103</xref>]. In particular, it has been demonstrated that in these patients, RBCs show ultrastructural alterations that could be countered by treatment with the antioxidizing drug <italic>N</italic>-acetylcysteine [<xref ref-type="bibr" rid="B103">103</xref>].</p>
<p>Importantly, altered RBC could represent a biomarker playing a critical role in the cardiovascular complications associated with metabolic diseases.</p>
</sec>
<sec id="sec3.5">
<title>3.5. Gut Microbiota in MS</title>
<p>The human intestinal tract constitutes a nutrient-rich environment colonized by a highly diversified microbial species, collectively called “gut microbiota.” Endotoxin derived by microbial species triggers inflammation, leading to MS and contributing to OS. Growing evidence indicates that nutrients and environmental factors are tightly associated with ROS/RNS generation and gut microbiota and that nutritional factors such as certain natural compounds and nutraceuticals may ameliorate oxidative through the change of the microbiota [<xref ref-type="bibr" rid="B104">104</xref>]. Diets with elevated intake of high-energy foods have long been considered as a factor in the onset of MS and related diseases. Several studies on animals and humans have showed that consumption of diets rich in sugars and fat induces obesity, dyslipidemia, and insulin resistance, three of major MS components [<xref ref-type="bibr" rid="B105">105</xref>–<xref ref-type="bibr" rid="B109">109</xref>]. Nevertheless, the mechanisms by which these diets contribute to the pathogenesis of MS are not completely understood.</p>
<p>Studies on healthy adults have revealed that the gut microbial composition is highly host-specific. In fact, there is an elevated interindividual variation in terms of species, strain composition, and abundance and that this may contribute to variations in normal physiology and metabolism [<xref ref-type="bibr" rid="B109">109</xref>–<xref ref-type="bibr" rid="B113">113</xref>]. Moreover, it has been suggested that gut microbiota specificity is also determined by host genotype, age, sex, and health state [<xref ref-type="bibr" rid="B113">113</xref>, <xref ref-type="bibr" rid="B114">114</xref>].</p>
<p>Gut microbiota participates in food digestion through two main catabolic pathways categorized as saccharolytic, with the production of the majority of short-chain fatty acid (SCFA), or proteolytic, which also induces SCFA formation, but leads to other co-metabolites potentially toxic predominantly renally cleared [<xref ref-type="bibr" rid="B115">115</xref>–<xref ref-type="bibr" rid="B117">117</xref>]. Furthermore, it has been reported that microbiota constitutes and regulates the intestinal mucosal barriers, controls nutrient uptake and metabolism, assists with maturation of immunological tissues, and prevents propagation of pathogenic microorganisms [<xref ref-type="bibr" rid="B117">117</xref>–<xref ref-type="bibr" rid="B120">120</xref>].</p>
<p>Studies on animal models and humans have also shown that changes in diet are associated with alterations in the composition and diversity of the community gut microbes and metabolic functions [<xref ref-type="bibr" rid="B109">109</xref>, <xref ref-type="bibr" rid="B113">113</xref>, <xref ref-type="bibr" rid="B121">121</xref>–<xref ref-type="bibr" rid="B128">128</xref>].</p>
<p>In particular, in animal models it has been shown that consumption of fructose, a major component of the Western-style diet, alters gut microbiota composition and induces several markers of the metabolic syndrome, inflammation, and OS. The fructose-rich diet also results in increased plasma levels of nonesterified fatty acid, plasmatic levels of bacterial lipopolysaccharide (LPS), and tumor necrosis factor (TNF-<italic>α</italic>) [<xref ref-type="bibr" rid="B125">125</xref>].</p>
<p>In humans, it has been suggested that both quantity and type of diet (fat or carbohydrate) can modify gut microbiota composition and also this can determine the development and rising incidence of obesity and MS [<xref ref-type="bibr" rid="B109">109</xref>, <xref ref-type="bibr" rid="B122">122</xref>, <xref ref-type="bibr" rid="B129">129</xref>–<xref ref-type="bibr" rid="B132">132</xref>].</p>
<p>Recent dietary interventions in subjects with high risk of developing CVD have shown that diets rich in fruit and vegetables improve cardiovascular health and impact on the gut microbiota [<xref ref-type="bibr" rid="B133">133</xref>–<xref ref-type="bibr" rid="B135">135</xref>]. In particular, the FLAVURS study showed that increasing the consumption of fruit and vegetables up to six 80 g portions daily caused a significant increase in total urinary flavonoids, vitamin C, and other phytochemicals [<xref ref-type="bibr" rid="B135">135</xref>–<xref ref-type="bibr" rid="B137">137</xref>].</p>
<p>Another strategy of modulating intestinal microbiota is by using of prebiotics. They are defined as live microorganisms used to reestablish an appropriate intestinal balance. They may potentially act through different mechanisms including pH modulation, antibacterial compound production, and competition with pathogens [<xref ref-type="bibr" rid="B113">113</xref>, <xref ref-type="bibr" rid="B117">117</xref>, <xref ref-type="bibr" rid="B138">138</xref>].</p>
<p>Typical prebiotics are mainly, although not all, dietary sources of fibers. In some studies, prebiotic administration is associated with both improved glycemic control and plasma lipid profiles [<xref ref-type="bibr" rid="B117">117</xref>, <xref ref-type="bibr" rid="B128">128</xref>, <xref ref-type="bibr" rid="B139">139</xref>, <xref ref-type="bibr" rid="B140">140</xref>].</p>
<p>It is possible that there may be other factors or mediators yet to be discovered that link gut microbiota to MS. More research is needed to elucidate the several mechanisms underlying diet–gut microbiota–host relationships that determine the development of MS. Main functions of bacteria in the gut are shown in <xref ref-type="fig" rid="fig3">Figure 3</xref>.</p>
</sec>
<sec id="sec3.6">
<title>3.6. Antioxidant Systems and Antioxidant Therapy in MS</title>
<p>A significant decrease in the activity/expression of antioxidant systems has been found in MS patients. Cu, ZnSOD, Gpx, and CAT activity was lower in RBCs of obese women compared with cells of a normal weight group [<xref ref-type="bibr" rid="B141">141</xref>]. Interestingly, under inflammatory conditions, which characterize also MS, the expression of Gpx isoform 1 and MnSOD has been found downregulated as a consequence of the suppression of the transcription factor p53, leading to the increase in ROS formation and oxidative damage [<xref ref-type="bibr" rid="B142">142</xref>]. In addition to this, the decrease in p53 expression leads to adipose tissue inflammation, local insulin resistance, and cardiometabolic disorders [<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B143">143</xref>]. Furthermore, in addition to several biomarkers of OS (ox-LDL, 3-nitrotyrosine, monocyte O<sub>2</sub><sup><underline>•</underline></sup> formation, and NOX activity), low amounts of the antioxidant defense nuclear factor E2-related factor 2 (Nrf2) have been measured in blood of patients with MS. Nrf2 is an important antioxidant factor involved in controlling the nuclear transcription of antioxidant enzymes, such as GR, aldo-keto-reductase, heme-oxygenase-1, and <italic>γ</italic>-glutamyl-cysteine synthetase [<xref ref-type="bibr" rid="B144">144</xref>, <xref ref-type="bibr" rid="B145">145</xref>].</p>
<p>Decreased levels of GSH have been measured in blood plasma as well as in RBCs [<xref ref-type="bibr" rid="B141">141</xref>] of MS patients, as well as reduced GSH/GSSG ratio animal models of obesity [<xref ref-type="bibr" rid="B50">50</xref>]. Interestingly, in addition to GSH depletion, a decreased activity of glucose-6-phosphate dehydrogenase, GR, and Gpx has been found in the serum of T2D patients [<xref ref-type="bibr" rid="B146">146</xref>]. As the main intracellular source of NADPH, a suitable activity of glucose-6-phosphate dehydrogenase is essential to maintain intracellular redox equilibrium. Therefore, the hyperglycemia-dependent inhibition of its activity in diabetic patients may have important repercussions on the entire NADPH-dependent antioxidant detoxifying system controlling the intracellular redox status. Moreover, under hyperglycemic conditions, the polyol pathway is the preferential way of glucose consumption [<xref ref-type="bibr" rid="B146">146</xref>]. The increased glucose flux in this pathway leads to (i) increased NADPH consumption in the conversion of glucose to sorbitol, (ii) increased NADH concentration, and (iii) decreased GSSG concentration linked to the downregulation of GR activity [<xref ref-type="bibr" rid="B146">146</xref>]. The increased NADH concentration could contribute to the increased OS linked to hyperglycemia, by favoring an overflux and recycling of NADH through the mitochondrial electron transport chain leading to ROS hyperproduction [<xref ref-type="bibr" rid="B146">146</xref>]. Moreover, under NADPH depletion conditions, the enzymes that use this cofactor as an electron donor cofactor, including NOXs and NOS, could also undergo to malfunction with important collateral effects such as vasoconstriction and platelet aggregation.</p>
<p>Finally, significantly elevated TrxR activity and Trx content have been measured in adipocytes present in subcutaneous tissue of obese people with metabolic disturbances, compared to metabolically healthy obese and control subjects [<xref ref-type="bibr" rid="B147">147</xref>]. The Trx/TrxR system could have a protective role in MS adipocytes and could represent an adaptive response to the altered redox environment [<xref ref-type="bibr" rid="B147">147</xref>, <xref ref-type="bibr" rid="B148">148</xref>].</p>
<p>Therapeutic strategies aimed at reducing OS and enhancing antioxidant defense have been employed to restore redox balance and consequently to reduce cardiac dysfunction in the MS and related CDV diseases.</p>
<p>Some foods and some specific nutritional components have received special attention for the treatment of MS and related diseases. A diet with a higher total antioxidant capacity (TAC) in plasma has been associated with low OS low risk of abdominal obesity and diabetes mellitus. TAC is an indicator of diet quality defined as the sum of antioxidant activities of the pool of antioxidants present in a food [<xref ref-type="bibr" rid="B149">149</xref>]. Its concept was introduced because the evaluation of individual antioxidants does not reflect the antioxidant capacity of a whole diet or the interactions and synergistic effects of various antioxidants.</p>
<p>Mediterranean diet takes an adequate intake of fruits, vegetables, cereals, legume, fish, nut, red wine, and olive oil, which contain several nutritional components with anti-inflammatory and antioxidant properties [<xref ref-type="bibr" rid="B149">149</xref>, <xref ref-type="bibr" rid="B150">150</xref>].</p>
<p>The PREDIMED study, a multicenter, randomized, controlled clinical trial, has shown that a Mediterranean diet increases TAC levels in subjects at high risk of cardiovascular disease [<xref ref-type="bibr" rid="B151">151</xref>].</p>
<p>The majority of clinical trials and studies in animal models of MS have been performed by using bioactive nutraceuticals from functional food, in particular vitamins (such as vitamins C and E), carotenoids, flavonoids, polyphenols, and selenium, which prevent the CVD in MS patients, although the underlying mechanisms were not fully elucidated for most of these compounds [<xref ref-type="bibr" rid="B152">152</xref>].</p>
<p>Vitamin C is an essential nutrient mainly found in fruits, especially citrus (lemon and orange), and vegetables (pepper and kale), whose benefits are associated with its antioxidant and anti-inflammatory properties. It produces its antioxidant effect primarily by quenching damaging free radicals and other reactive oxygen and nitrogen species and therefore preventing molecules such as ox-LDL [<xref ref-type="bibr" rid="B149">149</xref>].</p>
<p>Vitamin E, a fat-soluble phenolic compound contained in vegetable oils, is able to reduce OS and total cholesterol in patients with MS [<xref ref-type="bibr" rid="B153">153</xref>]. In diabetic patients, the supplementation of vitamins C and E, alone or together, significantly lowered hypertension, decreased hyperglycemia, and increased antioxidant activity, in particular the one of SOD and Gpx [<xref ref-type="bibr" rid="B153">153</xref>, <xref ref-type="bibr" rid="B154">154</xref>]. Contrarily, in another study the combination of vitamins C and E did not affect body weights, glycated hemoglobin, LDL, or triglyceride amounts of patients with the MS or T2D [<xref ref-type="bibr" rid="B154">154</xref>]. On the other hand, vitamin C administration in an animal model contributed to lower hypertension by preventing the OS-mediated oxidation of the cofactor BH4 preventing NOS uncoupling [<xref ref-type="bibr" rid="B155">155</xref>]. With respect to the above vitamins, polyphenols and flavonoid<bold>s</bold> showed a greater efficacy in reducing metabolic and cardiac dysfunctions characterizing MS.</p>
<p>It has been reported that resveratrol (3,5,40-trihydroxystilbene), a phenolic compound mainly found in red grapes and derived products (red wine, grape juice), exerts antioxidant and anti-inflammatory activities, by inhibiting NF<italic>κ</italic>B signaling [<xref ref-type="bibr" rid="B156">156</xref>]. In an animal model, it protects the heart, coronary artery, and liver from dysfunctions generated by a high-fat and sugar-fed diet [<xref ref-type="bibr" rid="B157">157</xref>, <xref ref-type="bibr" rid="B158">158</xref>]. In obese patients, it reduces insulin, glucose, and lipid concentrations in blood, as well as improving mitochondrial functions in skeletal muscle [<xref ref-type="bibr" rid="B159">159</xref>]. In a randomized, double-blind, placebo-controlled trial conducted on 50 MS patients treated for 8 weeks with red yeast rice-olive extract supplement, containing monacolin K and hydroxytyrosol, a reduction in total cholesterol, triacylglycerol, and ox-LDL has been demonstrated. No effects on plasmatic levels of MDA and 8-OHdG were detected [<xref ref-type="bibr" rid="B160">160</xref>].</p>
<p>Quercetin, a flavanol naturally present in vegetables, fruits, green tea, or red wine, reduces blood pressure and ox-LDL in blood plasma in overweight subjects with high cardiovascular disease risk [<xref ref-type="bibr" rid="B161">161</xref>]. Improved cardiac functions have been obtained by quercetin in animal models submitted to high-carbohydrate and high-fat diet [<xref ref-type="bibr" rid="B162">162</xref>].</p>
<p>Moreover, it has been reported that curcuminoid, sulforaphane, and epigallocatechin were effective in controlling hyperglycemia and improving the antioxidant response mediated by Nrf2 [<xref ref-type="bibr" rid="B163">163</xref>–<xref ref-type="bibr" rid="B165">165</xref>].</p>
<p>Curcuminoids are bioactive principles of the famous dietary spice, having a polyphenolic structure. A meta-analysis of randomized controlled trials shows that supplementation with curcuminoid-piperine combination significantly improves oxidative and inflammatory status in patients with MS [<xref ref-type="bibr" rid="B166">166</xref>].</p>
</sec>
<sec id="sec3.7">
<title>3.7. Mitochondrial Dysfunction as Therapeutic Target</title>
<p>As reported above, mitochondria could contribute to the pathogenesis of MS with increased ROS production, alteration of energy metabolism, and dysfunction of the mitophagy process. Therefore, it is possible that it develops a strategy aimed at preventing mitochondrial dysfunction [<xref ref-type="bibr" rid="B167">167</xref>, <xref ref-type="bibr" rid="B168">168</xref>]. The focus of these studies was to choose compounds with antioxidant capacity showing high mitochondrial affinity, such as SOD mimetics (pharmacological mimetics of antioxidant enzyme), coenzyme Q10 (a vitamin-like, lipid-soluble component of the mitochondrial electron-transport chain), and MitoQ (a triphenylphosphonium-conjugated derivative of coenzyme Q). Studies <italic>in vitro</italic> showed that SOD mimetics were effective in reducing ROS and restoring mitochondrial function [<xref ref-type="bibr" rid="B169">169</xref>], while in animal models of obesity, SOD mimetic and ONOO<sup>−</sup> scavenger improved glucose tolerance [<xref ref-type="bibr" rid="B169">169</xref>]. Contrasting results were obtained in patients with MS, in which the addition of coenzyme Q10 to regular clinical therapy reduced diastolic dysfunction in children with cardiomyopathy [<xref ref-type="bibr" rid="B170">170</xref>], while the supplementation with the antioxidant was not sufficient to reduce hypertension in patients with the MS [<xref ref-type="bibr" rid="B170">170</xref>, <xref ref-type="bibr" rid="B171">171</xref>]. In animal models of obesity, coenzyme Q10 supplementation reduced ROS formation and lipid peroxidation and ameliorated pressure parameters [<xref ref-type="bibr" rid="B172">172</xref>].</p>
<p>The use of MitoQ in animal models ameliorated cardiac dysfunction in rats subjected to ischemia/reperfusion [<xref ref-type="bibr" rid="B173">173</xref>] and decreased adiposity, hypercholesterolemia, and hypertriglyceridemia in high fat-fed mouse in models of MS [<xref ref-type="bibr" rid="B174">174</xref>]. No studies have yet been undertaken regarding the use MitoQ in clinical studies for human MS. The combined supplementation of MitoQ and MitoTEMPOL, another mitochondria-targeted antioxidant, improved mitochondrial activity and protected the coronary artery in rats subjected to ischemia/reperfusion [<xref ref-type="bibr" rid="B175">175</xref>].</p>
</sec>
</sec>
<sec id="sec4">
<title>4. Conclusions</title>
<p>Several lines of experimental and clinical evidences indicate that OS and redox imbalance play a pivotal role in the development of CDV linked to MS. The risk factors associated with MS, including obesity, diabetes, dyslipidemia, hypertension, and impaired glucose tolerance, are characterized by the persistence of OS-mediated chronic inflammatory conditions, as indicated by the occurrence of specific biomarkers in tissues from animals as well as from MS patients. OS may occur by multiple mechanisms, with prominent roles attributable to mitochondrial dysfunction, ROS/RNS-producing enzyme activation, and impairment of antioxidant system activity. Beyond its occurrence, it remains unclear whether OS may be the cause or consequence of MS. This is particularly important for mitochondrial-derived OS and dysfunction, which could be the main sources of oxidative damage and metabolic alterations in MS. Controversial findings have been obtained by using antioxidant therapies aimed at counteracting systemic as well as mitochondrial-derived OS. Other studies and clinical trials, by clarifying the mechanisms linking OS to MS, will allow developing specific and more suitable therapeutic approaches aimed not only at the control of oxidizing species formation but also at developing preventive strategies focused on limiting the occurrence and the progression of the cardiovascular risk factors.</p>
<p>Several factors link gut microbiota to MS. In fact, many data suggest that the gut microbiota has important physiological functions having a direct impact not only on host metabolism but also on gut mucosal barrier development and both local and systemic immune functions. Targeting gut microbiota composition or metabolic functions with natural and safe compounds, such as pro- or prebiotics, to promote a healthier profile might represent, indeed, a promising tool for prevention and treatment of obesity and correlated diseases.</p>
<p>Since OS has emerged as a central player in chronic metabolic diseases, it is imperative to (i) explore further the mechanisms that disrupt the normal equilibrium between oxidative and antioxidative processes; (ii) integrate the current therapies with various nutritional antioxidants such as flavonoids, arginine, vitamin C, vitamin E, carotenoids, resveratrol, and selenium capable of neutralizing OS; and (iii) prevent mitochondrial dysfunction to enhance defenses against OS.</p>
</sec>
</body>
<back>
<ack>
<title>Acknowledgments</title>
<p>This study was supported in part by a grant from the Ministry of Health (RF-2013-02358715) awarded to E.S. The authors thank Ms. Carlotta Catalano for the linguistic revision of the manuscript.</p>
</ack>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>8oxodG:</term>
<def>
<p>8-Oxo-2′-deoxyguanosine</p>
</def>
</def-item>
<def-item>
<term>AGE:</term>
<def>
<p>Advanced glycation end products</p>
</def>
</def-item>
<def-item>
<term>ATP:</term>
<def>
<p>Adenosine triphosphate</p>
</def>
</def-item>
<def-item>
<term>BH4:</term>
<def>
<p>(6R)-5,6,7,8-Tetrahydro-L-biopterin</p>
</def>
</def-item>
<def-item>
<term>CAT:</term>
<def>
<p>Catalase</p>
</def>
</def-item>
<def-item>
<term>COX:</term>
<def>
<p>Cyclooxygenase</p>
</def>
</def-item>
<def-item>
<term>CuZnSOD:</term>
<def>
<p>Copper-zinc superoxide dismutase</p>
</def>
</def-item>
<def-item>
<term>CVD:</term>
<def>
<p>Cardiovascular diseases</p>
</def>
</def-item>
<def-item>
<term>DUOX:</term>
<def>
<p>Dual oxidases</p>
</def>
</def-item>
<def-item>
<term>EC-SOD:</term>
<def>
<p>Extracellular superoxide dismutase</p>
</def>
</def-item>
<def-item>
<term>eNOS:</term>
<def>
<p>Endothelial nitric oxide synthase</p>
</def>
</def-item>
<def-item>
<term>EPR:</term>
<def>
<p>Electron paramagnetic resonance</p>
</def>
</def-item>
<def-item>
<term>FFAs:</term>
<def>
<p>Free fatty acids</p>
</def>
</def-item>
<def-item>
<term>Gl-LDL:</term>
<def>
<p>Glycated low-density lipoprotein</p>
</def>
</def-item>
<def-item>
<term>Gpx:</term>
<def>
<p>Glutathione peroxidase</p>
</def>
</def-item>
<def-item>
<term>GR:</term>
<def>
<p>Glutathione reductase</p>
</def>
</def-item>
<def-item>
<term>Grx:</term>
<def>
<p>Glutaredoxin</p>
</def>
</def-item>
<def-item>
<term>GSH:</term>
<def>
<p>Reduced glutathione</p>
</def>
</def-item>
<def-item>
<term>GSSG:</term>
<def>
<p>Oxidized glutathione</p>
</def>
</def-item>
<def-item>
<term>HDL:</term>
<def>
<p>High-density lipoprotein</p>
</def>
</def-item>
<def-item>
<term>HNE:</term>
<def>
<p>4-Hydroxy-2-nonenal</p>
</def>
</def-item>
<def-item>
<term>IL-6:</term>
<def>
<p>Interleukin-6</p>
</def>
</def-item>
<def-item>
<term>iNOS:</term>
<def>
<p>Inducible nitric oxide synthase</p>
</def>
</def-item>
<def-item>
<term>LDL:</term>
<def>
<p>Low-density lipoprotein</p>
</def>
</def-item>
<def-item>
<term>LOOH:</term>
<def>
<p>Lipid hydroperoxide</p>
</def>
</def-item>
<def-item>
<term>LOX:</term>
<def>
<p>Lipoxygenase</p>
</def>
</def-item>
<def-item>
<term>LPS:</term>
<def>
<p>Lipopolysaccharide</p>
</def>
</def-item>
<def-item>
<term>MCP-1:</term>
<def>
<p>Monocyte chemoattractant protein-1</p>
</def>
</def-item>
<def-item>
<term>MDA:</term>
<def>
<p>Malondialdehyde</p>
</def>
</def-item>
<def-item>
<term>MnSOD:</term>
<def>
<p>Manganese superoxide dismutase</p>
</def>
</def-item>
<def-item>
<term>MPO:</term>
<def>
<p>Myeloperoxidase</p>
</def>
</def-item>
<def-item>
<term>MS:</term>
<def>
<p>Metabolic syndrome</p>
</def>
</def-item>
<def-item>
<term>NF<italic>κ</italic>B:</term>
<def>
<p>Nuclear factor kappa-light-chain-enhancer of activated B cells</p>
</def>
</def-item>
<def-item>
<term>nNOS:</term>
<def>
<p>Neuronal nitric oxide synthase</p>
</def>
</def-item>
<def-item>
<term>NOS:</term>
<def>
<p>Nitric oxide synthase</p>
</def>
</def-item>
<def-item>
<term>NOXs:</term>
<def>
<p>NADPH oxidase isoforms</p>
</def>
</def-item>
<def-item>
<term>Nrf2:</term>
<def>
<p>Nuclear factor E2-related factor 2</p>
</def>
</def-item>
<def-item>
<term>OS:</term>
<def>
<p>Oxidative stress</p>
</def>
</def-item>
<def-item>
<term>ox-LDL:</term>
<def>
<p>Oxidized low-density lipoprotein</p>
</def>
</def-item>
<def-item>
<term>PGC-1a:</term>
<def>
<p>Proliferator-activated receptor gamma coactivator 1a</p>
</def>
</def-item>
<def-item>
<term>PKC:</term>
<def>
<p>Protein kinase C</p>
</def>
</def-item>
<def-item>
<term>Prx:</term>
<def>
<p>Peroxiredoxin</p>
</def>
</def-item>
<def-item>
<term>PUFAs:</term>
<def>
<p>Polyunsaturated fatty acids</p>
</def>
</def-item>
<def-item>
<term>RAGE:</term>
<def>
<p>Soluble receptor of AGE</p>
</def>
</def-item>
<def-item>
<term>RBCs:</term>
<def>
<p>Red blood cells</p>
</def>
</def-item>
<def-item>
<term>RNS:</term>
<def>
<p>Reactive nitrogen species</p>
</def>
</def-item>
<def-item>
<term>RO<sup>•</sup>:</term>
<def>
<p>Alkoxyl radical</p>
</def>
</def-item>
<def-item>
<term>ROO<sup>•</sup>:</term>
<def>
<p>Peroxyl radicals</p>
</def>
</def-item>
<def-item>
<term>ROS:</term>
<def>
<p>Reactive oxygen species</p>
</def>
</def-item>
<def-item>
<term>RS<sup>•</sup>:</term>
<def>
<p>Thiyl radicals</p>
</def>
</def-item>
<def-item>
<term>SCFA:</term>
<def>
<p>Short-chain fatty acids</p>
</def>
</def-item>
<def-item>
<term>SOD:</term>
<def>
<p>Superoxide dismutase</p>
</def>
</def-item>
<def-item>
<term>T2D:</term>
<def>
<p>Type 2 diabetes</p>
</def>
</def-item>
<def-item>
<term>TAC:</term>
<def>
<p>Total antioxidant capacity</p>
</def>
</def-item>
<def-item>
<term>TNF-<italic>α</italic>:</term>
<def>
<p>Tumor necrosis factor</p>
</def>
</def-item>
<def-item>
<term>TNF-<italic>α</italic>:</term>
<def>
<p>Tumor necrosis factor alpha</p>
</def>
</def-item>
<def-item>
<term>TO<sup>•</sup>:</term>
<def>
<p>Tocopheroxyl radicals</p>
</def>
</def-item>
<def-item>
<term>Trx:</term>
<def>
<p>Thioredoxin</p>
</def>
</def-item>
<def-item>
<term>TrxR:</term>
<def>
<p>Thioredoxin reductase.</p>
</def>
</def-item>
</def-list>
</glossary>
<sec>
<title>Conflicts of Interest</title>
<p>The authors declare that there is no conflict of interest regarding the publication of this paper.</p>
</sec>
<sec>
<title>Authors' Contributions</title>
<p>Elisabetta Straface and Donatella Pietraforte contributed equally to this work.</p>
</sec>
<ref-list>
<ref id="B1">
<label>1</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spahis</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Borys</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Metabolic syndrome as a multifaceted risk factor for oxidative stress</article-title>
<source/>
<italic toggle="yes">Antioxidants &amp; Redox Signaling</italic>
<year>2017</year>
<volume>26</volume>
<issue>9</issue>
<fpage>445</fpage>
<lpage>461</lpage>
<pub-id pub-id-type="doi">10.1089/ars.2016.6756</pub-id>
<pub-id pub-id-type="other">2-s2.0-85015155111</pub-id>
<pub-id pub-id-type="pmid">27302002</pub-id>
</element-citation>
</ref>
<ref id="B2">
<label>2</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roberts</surname>
<given-names>C. K.</given-names>
</name>
<name>
<surname>Sindhu</surname>
<given-names>K. K.</given-names>
</name>
</person-group>
<article-title>Oxidative stress and metabolic syndrome</article-title>
<source/>
<italic toggle="yes">Life Sciences</italic>
<year>2009</year>
<volume>84</volume>
<issue>21-22</issue>
<fpage>705</fpage>
<lpage>712</lpage>
<pub-id pub-id-type="doi">10.1016/j.lfs.2009.02.026</pub-id>
<pub-id pub-id-type="other">2-s2.0-67349091737</pub-id>
<pub-id pub-id-type="pmid">19281826</pub-id>
</element-citation>
</ref>
<ref id="B3">
<label>3</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palmieri</surname>
<given-names>V. O.</given-names>
</name>
<name>
<surname>Grattagliano</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Portincasa</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Palasciano</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Systemic oxidative alterations are associated with visceral adiposity and liver steatosis in patients with metabolic syndrome</article-title>
<source/>
<italic toggle="yes">Journal of Nutrition</italic>
<year>2006</year>
<volume>136</volume>
<issue>12</issue>
<fpage>3022</fpage>
<lpage>3026</lpage>
<pub-id pub-id-type="doi">10.1093/jn/136.12.3022</pub-id>
<pub-id pub-id-type="pmid">17116714</pub-id>
</element-citation>
</ref>
<ref id="B4">
<label>4</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Armutcu</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ataymen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Atmaca</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Gurel</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome</article-title>
<source/>
<italic toggle="yes">Clinical Chemistry and Laboratory Medicine</italic>
<year>2008</year>
<volume>46</volume>
<issue>6</issue>
<fpage>785</fpage>
<lpage>790</lpage>
<pub-id pub-id-type="doi">10.1515/CCLM.2008.166</pub-id>
<pub-id pub-id-type="other">2-s2.0-44949130582</pub-id>
<pub-id pub-id-type="pmid">18601599</pub-id>
</element-citation>
</ref>
<ref id="B5">
<label>5</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furukawa</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fujita</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Shimabukuro</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased oxidative stress in obesity and its impact on metabolic syndrome</article-title>
<source/>
<italic toggle="yes">The Journal of Clinical Investigation</italic>
<year>2004</year>
<volume>114</volume>
<issue>12</issue>
<fpage>1752</fpage>
<lpage>1761</lpage>
<pub-id pub-id-type="doi">10.1172/JCI21625</pub-id>
<pub-id pub-id-type="other">2-s2.0-85030434746</pub-id>
<pub-id pub-id-type="pmid">15599400</pub-id>
</element-citation>
</ref>
<ref id="B6">
<label>6</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zelzer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fuchs</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Almer</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High density lipoprotein cholesterol level is a robust predictor of lipid peroxidation irrespective of gender, age, obesity, and inflammatory or metabolic biomarkers</article-title>
<source/>
<italic toggle="yes">Clinica Chimica Acta</italic>
<year>2011</year>
<volume>412</volume>
<issue>15-16</issue>
<fpage>1345</fpage>
<lpage>1349</lpage>
<pub-id pub-id-type="doi">10.1016/j.cca.2011.03.031</pub-id>
<pub-id pub-id-type="other">2-s2.0-79956334078</pub-id>
</element-citation>
</ref>
<ref id="B7">
<label>7</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Perez-Pozo</surname>
<given-names>S. E.</given-names>
</name>
<name>
<surname>Schold</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Nakagawa</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Sánchez-Lozada</surname>
<given-names>L. G.</given-names>
</name>
<name>
<surname>Johnson</surname>
<given-names>R. J.</given-names>
</name>
<name>
<surname>Lillo</surname>
<given-names>J. L.</given-names>
</name>
</person-group>
<article-title>Excessive fructose intake induces the features of metabolic syndrome in healthy adult men: role of uric acid in the hypertensive response</article-title>
<source/>
<italic toggle="yes">International Journal of Obesity</italic>
<year>2010</year>
<volume>34</volume>
<issue>3</issue>
<fpage>454</fpage>
<lpage>461</lpage>
<pub-id pub-id-type="doi">10.1038/ijo.2009.259</pub-id>
<pub-id pub-id-type="other">2-s2.0-77949541626</pub-id>
<pub-id pub-id-type="pmid">20029377</pub-id>
</element-citation>
</ref>
<ref id="B8">
<label>8</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mirmiran</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Hadavi</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Mottaghi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Azizi</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Effect of dietary patterns on oxidative stress in patients with metabolic syndrome: Tehran Lipid and Glucose Study</article-title>
<source/>
<italic toggle="yes">Caspian Journal of Internal Medicine</italic>
<year>2018</year>
<volume>9</volume>
<issue>4</issue>
<fpage>376</fpage>
<lpage>385</lpage>
<pub-id pub-id-type="doi">10.22088/cjim.9.4.376</pub-id>
<pub-id pub-id-type="other">2-s2.0-85058050386</pub-id>
<pub-id pub-id-type="pmid">30510653</pub-id>
</element-citation>
</ref>
<ref id="B9">
<label>9</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janssen-Heininger</surname>
<given-names>Y. M. W.</given-names>
</name>
<name>
<surname>Mossman</surname>
<given-names>B. T.</given-names>
</name>
<name>
<surname>Heintz</surname>
<given-names>N. H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Redox-based regulation of signal transduction: principles, pitfalls, and promises</article-title>
<source/>
<italic toggle="yes">Free Radical Biology and Medicine</italic>
<year>2008</year>
<volume>45</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2008.03.011</pub-id>
<pub-id pub-id-type="other">2-s2.0-45049085873</pub-id>
<pub-id pub-id-type="pmid">18423411</pub-id>
</element-citation>
</ref>
<ref id="B10">
<label>10</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chiurchiù</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Maccarrone</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Chronic inflammatory disorders and their redox control: from molecular mechanisms to therapeutic opportunities</article-title>
<source/>
<italic toggle="yes">Antioxidants &amp; Redox Signaling</italic>
<year>2011</year>
<volume>15</volume>
<issue>9</issue>
<fpage>2605</fpage>
<lpage>2641</lpage>
<pub-id pub-id-type="doi">10.1089/ars.2010.3547</pub-id>
<pub-id pub-id-type="other">2-s2.0-80053004011</pub-id>
<pub-id pub-id-type="pmid">21391902</pub-id>
</element-citation>
</ref>
<ref id="B11">
<label>11</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buettner</surname>
<given-names>G. R.</given-names>
</name>
<name>
<surname>Jurkiewicz</surname>
<given-names>B. A.</given-names>
</name>
</person-group>
<article-title>Ascorbate free radical as a marker of oxidative stress: an EPR study</article-title>
<source/>
<italic toggle="yes">Free Radical Biology and Medicine</italic>
<year>1993</year>
<volume>14</volume>
<issue>1</issue>
<fpage>49</fpage>
<lpage>55</lpage>
<pub-id pub-id-type="doi">10.1016/0891-5849(93)90508-R</pub-id>
<pub-id pub-id-type="other">2-s2.0-0027469054</pub-id>
<pub-id pub-id-type="pmid">8384150</pub-id>
</element-citation>
</ref>
<ref id="B12">
<label>12</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartberger</surname>
<given-names>M. D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The reduction potential of nitric oxide (NO) and its importance to NO biochemistry</article-title>
<source/>
<italic toggle="yes">Proceedings of the National Academy of Sciences of the United States of America</italic>
<year>2002</year>
<volume>99</volume>
<issue>17</issue>
<fpage>10958</fpage>
<lpage>10963</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.162095599</pub-id>
<pub-id pub-id-type="other">2-s2.0-0037143706</pub-id>
<pub-id pub-id-type="pmid">12177417</pub-id>
</element-citation>
</ref>
<ref id="B13">
<label>13</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goligorsky</surname>
<given-names>M. S.</given-names>
</name>
</person-group>
<article-title>Vascular endothelium in diabetes</article-title>
<source/>
<italic toggle="yes">American Journal of Physiology Renal Physiology</italic>
<year>2017</year>
<volume>312</volume>
<issue>2</issue>
<fpage>266</fpage>
<lpage>275</lpage>
</element-citation>
</ref>
<ref id="B14">
<label>14</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Dickhout</surname>
<given-names>J. G.</given-names>
</name>
<name>
<surname>Sandow</surname>
<given-names>S. L.</given-names>
</name>
</person-group>
<article-title>Vascular structural and functional changes: their association with causality in hypertension: models, remodeling and relevance</article-title>
<source/>
<italic toggle="yes">Hypertension Research</italic>
<year>2017</year>
<volume>40</volume>
<issue>4</issue>
<fpage>311</fpage>
<lpage>323</lpage>
<pub-id pub-id-type="doi">10.1111/bph.12960</pub-id>
<pub-id pub-id-type="other">2-s2.0-84923781545</pub-id>
<pub-id pub-id-type="pmid">27784889</pub-id>
</element-citation>
</ref>
<ref id="B15">
<label>15</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Horke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Habermeier</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Uncoupling of endothelial nitric oxide synthase in perivascular adipose tissue of diet-induced obese mice</article-title>
<source/>
<italic toggle="yes">Arteriosclerosis, Thrombosis, and Vascular Biology</italic>
<year>2016</year>
<volume>36</volume>
<issue>1</issue>
<fpage>78</fpage>
<lpage>85</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.115.306263</pub-id>
<pub-id pub-id-type="other">2-s2.0-84952638318</pub-id>
</element-citation>
</ref>
<ref id="B16">
<label>16</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eiserich</surname>
<given-names>J. P.</given-names>
</name>
<name>
<surname>Cross</surname>
<given-names>C. E.</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>A. D.</given-names>
</name>
<name>
<surname>Halliwell</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>van der Vliet</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Formation of nitrating and chlorinating species by reaction of nitrite with hypoch-lorous acid. A novel mechanism for nitric oxide-mediated protein modification</article-title>
<source/>
<italic toggle="yes">Journal of Biological Chemistry</italic>
<year>1996</year>
<volume>271</volume>
<issue>32</issue>
<fpage>19199</fpage>
<lpage>19208</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.271.32.19199</pub-id>
<pub-id pub-id-type="other">2-s2.0-0029760021</pub-id>
<pub-id pub-id-type="pmid">8702599</pub-id>
</element-citation>
</ref>
<ref id="B17">
<label>17</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nussbaum</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Klinke</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Adam</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Baldus</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sperandio</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease</article-title>
<source/>
<italic toggle="yes">Antioxidants &amp; Redox Signaling</italic>
<year>2013</year>
<volume>18</volume>
<issue>6</issue>
<fpage>692</fpage>
<lpage>713</lpage>
<pub-id pub-id-type="doi">10.1089/ars.2012.4783</pub-id>
<pub-id pub-id-type="other">2-s2.0-84872451042</pub-id>
<pub-id pub-id-type="pmid">22823200</pub-id>
</element-citation>
</ref>
<ref id="B18">
<label>18</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vona</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ascione</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Malorni</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Straface</surname>
<given-names>E.</given-names>
</name>
</person-group>
<article-title>Mitochondria and sex-specific cardiac function</article-title>
<source/>
<italic toggle="yes">Advances in Experimental Medicine and Biology</italic>
<year>2018</year>
<volume>1065</volume>
<fpage>241</fpage>
<lpage>256</lpage>
<pub-id pub-id-type="doi">10.1007/978-3-319-77932-4_16</pub-id>
<pub-id pub-id-type="other">2-s2.0-85051272142</pub-id>
<pub-id pub-id-type="pmid">30051389</pub-id>
</element-citation>
</ref>
<ref id="B19">
<label>19</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palmeira</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Moreno</surname>
<given-names>A. J.</given-names>
</name>
</person-group>
<article-title>Mitochondrial bioenergetics methods and protocols springer</article-title>
<source/>
<italic toggle="yes">Methods in Molecular Biology</italic>
<year>2012</year>
<volume>810</volume>
<fpage>381</fpage>
<lpage>383</lpage>
</element-citation>
</ref>
<ref id="B20">
<label>20</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossier</surname>
<given-names>M. F.</given-names>
</name>
</person-group>
<article-title>T channels and steroid biosynthesis: in search of a link with mitochondria</article-title>
<source/>
<italic toggle="yes">Cell Calcium</italic>
<year>2006</year>
<volume>40</volume>
<issue>2</issue>
<fpage>155</fpage>
<lpage>164</lpage>
<pub-id pub-id-type="doi">10.1016/j.ceca.2006.04.020</pub-id>
<pub-id pub-id-type="other">2-s2.0-33745410655</pub-id>
<pub-id pub-id-type="pmid">16759697</pub-id>
</element-citation>
</ref>
<ref id="B21">
<label>21</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhatraju</surname>
<given-names>N. K.</given-names>
</name>
<name>
<surname>Agrawal</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction linking obesity and asthma</article-title>
<source/>
<italic toggle="yes">Annals of the American Thoracic Society</italic>
<year>2017</year>
<volume>14</volume>
<issue>Supplement_5</issue>
<fpage>S368</fpage>
<lpage>S373</lpage>
<pub-id pub-id-type="doi">10.1513/AnnalsATS.201701-042AW</pub-id>
<pub-id pub-id-type="other">2-s2.0-85035123047</pub-id>
<pub-id pub-id-type="pmid">29161084</pub-id>
</element-citation>
</ref>
<ref id="B22">
<label>22</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Münzel</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gori</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Bruno</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Taddei</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Is oxidative stress a therapeutic target in cardiovascular disease?</article-title>
<source/>
<italic toggle="yes">European Heart Journal</italic>
<year>2010</year>
<volume>31</volume>
<issue>22</issue>
<fpage>2741</fpage>
<lpage>2748</lpage>
<pub-id pub-id-type="doi">10.1093/eurheartj/ehq396</pub-id>
<pub-id pub-id-type="other">2-s2.0-78649357316</pub-id>
<pub-id pub-id-type="pmid">20974801</pub-id>
</element-citation>
</ref>
<ref id="B23">
<label>23</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ray</surname>
<given-names>P. D.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Tsuji</surname>
<given-names>Y.</given-names>
</name>
</person-group>
<article-title>Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling</article-title>
<source/>
<italic toggle="yes">Cellular Signalling</italic>
<year>2012</year>
<volume>24</volume>
<issue>5</issue>
<fpage>981</fpage>
<lpage>990</lpage>
<pub-id pub-id-type="doi">10.1016/j.cellsig.2012.01.008</pub-id>
<pub-id pub-id-type="other">2-s2.0-84857116578</pub-id>
<pub-id pub-id-type="pmid">22286106</pub-id>
</element-citation>
</ref>
<ref id="B24">
<label>24</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Mitochondrial alteration in type 2 diabetes and obesity: an epigenetic link</article-title>
<source/>
<italic toggle="yes">Cell Cycle</italic>
<year>2014</year>
<volume>13</volume>
<issue>6</issue>
<fpage>890</fpage>
<lpage>897</lpage>
<pub-id pub-id-type="doi">10.4161/cc.28189</pub-id>
<pub-id pub-id-type="other">2-s2.0-84897975266</pub-id>
<pub-id pub-id-type="pmid">24552811</pub-id>
</element-citation>
</ref>
<ref id="B25">
<label>25</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsuzawa-Nagata</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Takamura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ando</surname>
<given-names>H.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Increased oxidative stress precedes the onset of high-fat diet–induced insulin resistance and obesity</article-title>
<source/>
<italic toggle="yes">Metabolism</italic>
<year>2008</year>
<volume>57</volume>
<issue>8</issue>
<fpage>1071</fpage>
<lpage>1077</lpage>
<pub-id pub-id-type="doi">10.1016/j.metabol.2008.03.010</pub-id>
<pub-id pub-id-type="other">2-s2.0-47149115165</pub-id>
<pub-id pub-id-type="pmid">18640384</pub-id>
</element-citation>
</ref>
<ref id="B26">
<label>26</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Tseng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>White</surname>
<given-names>M. F.</given-names>
</name>
</person-group>
<article-title>Insulin signaling meets mitochondria in metabolism</article-title>
<source/>
<italic toggle="yes">Trends in Endocrinology &amp; Metabolism</italic>
<year>2010</year>
<volume>21</volume>
<issue>10</issue>
<fpage>589</fpage>
<lpage>598</lpage>
<pub-id pub-id-type="doi">10.1016/j.tem.2010.06.005</pub-id>
<pub-id pub-id-type="other">2-s2.0-77957229010</pub-id>
<pub-id pub-id-type="pmid">20638297</pub-id>
</element-citation>
</ref>
<ref id="B27">
<label>27</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>S. D.</given-names>
</name>
<name>
<surname>McGee</surname>
<given-names>S. L.</given-names>
</name>
</person-group>
<article-title>The role of mitochondria in the aetiology of insulin resistance and type 2 diabetes</article-title>
<source/>
<italic toggle="yes">Biochimica et Biophysica Acta (BBA) - General Subjects</italic>
<year>2014</year>
<volume>1840</volume>
<issue>4</issue>
<fpage>1303</fpage>
<lpage>1312</lpage>
<pub-id pub-id-type="doi">10.1016/j.bbagen.2013.09.019</pub-id>
<pub-id pub-id-type="other">2-s2.0-84895555916</pub-id>
<pub-id pub-id-type="pmid">24060748</pub-id>
</element-citation>
</ref>
<ref id="B28">
<label>28</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gomes</surname>
<given-names>L. C.</given-names>
</name>
<name>
<surname>Benedetto</surname>
<given-names>G. D.</given-names>
</name>
<name>
<surname>Scorrano</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>During autophagy mitochondria elongate, are spared from degradation and sustain cell viability</article-title>
<source/>
<italic toggle="yes">Nature Cell Biology</italic>
<year>2011</year>
<volume>13</volume>
<issue>5</issue>
<fpage>589</fpage>
<lpage>598</lpage>
<pub-id pub-id-type="doi">10.1038/ncb2220</pub-id>
<pub-id pub-id-type="other">2-s2.0-79955623510</pub-id>
<pub-id pub-id-type="pmid">21478857</pub-id>
</element-citation>
</ref>
<ref id="B29">
<label>29</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rambold</surname>
<given-names>A. S.</given-names>
</name>
<name>
<surname>Kostelecky</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Elia</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Lippincott-Schwartz</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation</article-title>
<source/>
<italic toggle="yes">Proceedings of the National Academy of Sciences of the United States of America</italic>
<year>2011</year>
<volume>108</volume>
<issue>25</issue>
<fpage>10190</fpage>
<lpage>10195</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1107402108</pub-id>
<pub-id pub-id-type="other">2-s2.0-79959987510</pub-id>
<pub-id pub-id-type="pmid">21646527</pub-id>
</element-citation>
</ref>
<ref id="B30">
<label>30</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Keefe</surname>
<given-names>J. H.</given-names>
</name>
<name>
<surname>Bell</surname>
<given-names>D. S. H.</given-names>
</name>
</person-group>
<article-title>Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor</article-title>
<source/>
<italic toggle="yes">American Journal of Cardiology</italic>
<year>2007</year>
<volume>100</volume>
<issue>5</issue>
<fpage>899</fpage>
<lpage>904</lpage>
<pub-id pub-id-type="doi">10.1016/j.amjcard.2007.03.107</pub-id>
<pub-id pub-id-type="other">2-s2.0-34547957993</pub-id>
<pub-id pub-id-type="pmid">17719342</pub-id>
</element-citation>
</ref>
<ref id="B31">
<label>31</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marzetti</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Anne Lees</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Eva Wohlgemuth</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Leeuwenburgh</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Sarcopenia of aging: underlying cellular mechanisms and protection by calorie restriction</article-title>
<source/>
<italic toggle="yes">BioFactors</italic>
<year>2009</year>
<volume>35</volume>
<issue>1</issue>
<fpage>28</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1002/biof.5</pub-id>
<pub-id pub-id-type="other">2-s2.0-65549136627</pub-id>
<pub-id pub-id-type="pmid">19319843</pub-id>
</element-citation>
</ref>
<ref id="B32">
<label>32</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niemann</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Teschner</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Silber</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Rohrbach</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Obesity induces signs of premature cardiac aging in younger patients: the role of mitochondria</article-title>
<source/>
<italic toggle="yes">Journal of the American College of Cardiology</italic>
<year>2011</year>
<volume>57</volume>
<issue>5</issue>
<fpage>577</fpage>
<lpage>585</lpage>
<pub-id pub-id-type="doi">10.1016/j.jacc.2010.09.040</pub-id>
<pub-id pub-id-type="other">2-s2.0-79251478801</pub-id>
<pub-id pub-id-type="pmid">21272749</pub-id>
</element-citation>
</ref>
<ref id="B33">
<label>33</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelley</surname>
<given-names>D. E.</given-names>
</name>
<name>
<surname>He</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Menshikova</surname>
<given-names>E. V.</given-names>
</name>
<name>
<surname>Ritov</surname>
<given-names>V. B.</given-names>
</name>
</person-group>
<article-title>Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes</article-title>
<source/>
<italic toggle="yes">Diabetes</italic>
<year>2002</year>
<volume>51</volume>
<issue>10</issue>
<fpage>2944</fpage>
<lpage>2950</lpage>
<pub-id pub-id-type="doi">10.2337/diabetes.51.10.2944</pub-id>
<pub-id pub-id-type="other">2-s2.0-0036788293</pub-id>
<pub-id pub-id-type="pmid">12351431</pub-id>
</element-citation>
</ref>
<ref id="B34">
<label>34</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lahera</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>de las Heras</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>López-Farré</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Manucha</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Ferder</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Role of mitochondrial dysfunction in hypertension and obesity</article-title>
<source/>
<italic toggle="yes">Current Hypertension Reports</italic>
<year>2017</year>
<volume>19</volume>
<issue>2</issue>
<fpage>p. 11</fpage>
<pub-id pub-id-type="doi">10.1007/s11906-017-0710-9</pub-id>
<pub-id pub-id-type="other">2-s2.0-85013639228</pub-id>
<pub-id pub-id-type="pmid">28233236</pub-id>
</element-citation>
</ref>
<ref id="B35">
<label>35</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ploumi</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Daskalaki</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Tavernarakis</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Mitochondrial biogenesis and clearance: a balancing act</article-title>
<source/>
<italic toggle="yes">FEBS Journal</italic>
<year>2017</year>
<volume>284</volume>
<issue>2</issue>
<fpage>183</fpage>
<lpage>195</lpage>
<pub-id pub-id-type="doi">10.1111/febs.13820</pub-id>
<pub-id pub-id-type="other">2-s2.0-84981517030</pub-id>
<pub-id pub-id-type="pmid">27462821</pub-id>
</element-citation>
</ref>
<ref id="B36">
<label>36</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liesa</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shirihai</surname>
<given-names>O. S.</given-names>
</name>
</person-group>
<article-title>Mitochondrial dynamics in the regulation of nutrient utilization and energy expenditure</article-title>
<source/>
<italic toggle="yes">Cell Metabolism</italic>
<year>2013</year>
<volume>17</volume>
<issue>4</issue>
<fpage>491</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2013.03.002</pub-id>
<pub-id pub-id-type="other">2-s2.0-84875906572</pub-id>
<pub-id pub-id-type="pmid">23562075</pub-id>
</element-citation>
</ref>
<ref id="B37">
<label>37</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wardman</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Fluorescent and luminescent probes for measurement of oxidative and nitrosative species in cells and tissues: progress, pitfalls, and prospects</article-title>
<source/>
<italic toggle="yes">Free Radical Biology and Medicine</italic>
<year>2007</year>
<volume>43</volume>
<issue>7</issue>
<fpage>995</fpage>
<lpage>1022</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2007.06.026</pub-id>
<pub-id pub-id-type="other">2-s2.0-34548126843</pub-id>
<pub-id pub-id-type="pmid">17761297</pub-id>
</element-citation>
</ref>
<ref id="B38">
<label>38</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zielonka</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kalyanaraman</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Hydroethidine- and MitoSOX-derived red fluorescence is not a reliable indicator of intracellular superoxide formation: another inconvenient truth</article-title>
<source/>
<italic toggle="yes">Free Radical Biology and Medicine</italic>
<year>2010</year>
<volume>48</volume>
<issue>8</issue>
<fpage>983</fpage>
<lpage>1001</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2010.01.028</pub-id>
<pub-id pub-id-type="other">2-s2.0-77950515980</pub-id>
<pub-id pub-id-type="pmid">20116425</pub-id>
</element-citation>
</ref>
<ref id="B39">
<label>39</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zielonka</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Kalyanaraman</surname>
<given-names>B.</given-names>
</name>
</person-group>
<article-title>Small-molecule luminescent probes for the detection of cellular oxidizing and nitrating species</article-title>
<source/>
<italic toggle="yes">Free Radical Biology and Medicine</italic>
<year>2018</year>
<volume>128</volume>
<issue>3</issue>
<fpage>3</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2018.03.032</pub-id>
<pub-id pub-id-type="other">2-s2.0-85054207129</pub-id>
<pub-id pub-id-type="pmid">29567392</pub-id>
</element-citation>
</ref>
<ref id="B40">
<label>40</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zielonka</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zielonka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sikora</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Global profiling of reactive oxygen and nitrogen species in biological systems: high-throughput real-time analyses</article-title>
<source/>
<italic toggle="yes">The Journal of Biological Chemistry</italic>
<year>2012</year>
<volume>287</volume>
<issue>5</issue>
<fpage>2984</fpage>
<lpage>2995</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M111.309062</pub-id>
<pub-id pub-id-type="other">2-s2.0-84856248241</pub-id>
<pub-id pub-id-type="pmid">22139901</pub-id>
</element-citation>
</ref>
<ref id="B41">
<label>41</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lönn</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Dennis</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Stocker</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Actions of “antioxidants” in the protection against atherosclerosis</article-title>
<source/>
<italic toggle="yes">Free Radical Biology &amp; Medicine</italic>
<year>2012</year>
<volume>53</volume>
<issue>4</issue>
<fpage>863</fpage>
<lpage>884</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2012.05.027</pub-id>
<pub-id pub-id-type="other">2-s2.0-84864414278</pub-id>
<pub-id pub-id-type="pmid">22664312</pub-id>
</element-citation>
</ref>
<ref id="B42">
<label>42</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wolin</surname>
<given-names>M. S.</given-names>
</name>
</person-group>
<article-title>Reactive oxygen species and the control of vascular function</article-title>
<source/>
<italic toggle="yes">American Journal of Physiology-Heart and Circulatory Physiology</italic>
<year>2009</year>
<volume>296</volume>
<issue>3</issue>
<fpage>H539</fpage>
<lpage>H549</lpage>
<pub-id pub-id-type="doi">10.1152/ajpheart.01167.2008</pub-id>
<pub-id pub-id-type="other">2-s2.0-64049083005</pub-id>
<pub-id pub-id-type="pmid">19151250</pub-id>
</element-citation>
</ref>
<ref id="B43">
<label>43</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fernandez-Marcos</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Nóbrega-Pereira</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>NADPH: new oxygen for the ROS theory of aging</article-title>
<source/>
<italic toggle="yes">Oncotarget</italic>
<year>2016</year>
<volume>7</volume>
<issue>32</issue>
<fpage>50814</fpage>
<lpage>50815</lpage>
<pub-id pub-id-type="doi">10.18632/oncotarget.10744</pub-id>
<pub-id pub-id-type="other">2-s2.0-84982278717</pub-id>
<pub-id pub-id-type="pmid">27449104</pub-id>
</element-citation>
</ref>
<ref id="B44">
<label>44</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dalle-Donne</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Aldini</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Carini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Colombo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rossi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Milzani</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Protein carbonylation, cellular dysfunction, and disease progression</article-title>
<source/>
<italic toggle="yes">Journal of Cellular and Molecular Medicine</italic>
<year>2006</year>
<volume>10</volume>
<issue>2</issue>
<fpage>389</fpage>
<lpage>406</lpage>
<pub-id pub-id-type="doi">10.1111/j.1582-4934.2006.tb00407.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-33747173091</pub-id>
<pub-id pub-id-type="pmid">16796807</pub-id>
</element-citation>
</ref>
<ref id="B45">
<label>45</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marrocco</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Altieri</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Peluso</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Measurement and clinical significance of biomarkers of oxidative stress in humans</article-title>
<source/>
<italic toggle="yes">Oxidative Medicine and Cellular Longevity</italic>
<year>2017</year>
<volume>2017</volume>
<fpage>32</fpage>
<pub-id pub-id-type="publisher-id">6501046</pub-id>
<pub-id pub-id-type="doi">10.1155/2017/6501046</pub-id>
<pub-id pub-id-type="other">2-s2.0-85021927872</pub-id>
</element-citation>
</ref>
<ref id="B46">
<label>46</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Signorini</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>de Felice</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Durand</surname>
<given-names>T.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Isoprostanes and 4-hydroxy-2-nonenal: markers or mediators of disease? Focus on Rett syndrome as a model of autism spectrum disorder</article-title>
<source/>
<italic toggle="yes">Oxidative Medicine and Cellular Longevity</italic>
<year>2013</year>
<volume>2013</volume>
<fpage>10</fpage>
<pub-id pub-id-type="publisher-id">343824</pub-id>
<pub-id pub-id-type="doi">10.1155/2013/343824</pub-id>
<pub-id pub-id-type="other">2-s2.0-84880272443</pub-id>
</element-citation>
</ref>
<ref id="B47">
<label>47</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dianzani</surname>
<given-names>M. U.</given-names>
</name>
</person-group>
<article-title>4-Hydroxynonenal from pathology to physiology</article-title>
<source/>
<italic toggle="yes">Molecular Aspects of Medicine</italic>
<year>2003</year>
<volume>24</volume>
<issue>4-5</issue>
<fpage>263</fpage>
<lpage>272</lpage>
<pub-id pub-id-type="doi">10.1016/S0098-2997(03)00021-9</pub-id>
<pub-id pub-id-type="other">2-s2.0-0042671376</pub-id>
<pub-id pub-id-type="pmid">12893004</pub-id>
</element-citation>
</ref>
<ref id="B48">
<label>48</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Broedbaek</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Weimann</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Stovgaard</surname>
<given-names>E. S.</given-names>
</name>
<name>
<surname>Poulsen</surname>
<given-names>H. E.</given-names>
</name>
</person-group>
<article-title>Urinary 8-oxo-7,8-dihydro-2′-deoxyguanosine as a biomarker in type 2 diabetes</article-title>
<source/>
<italic toggle="yes">Free Radical Biology &amp; Medicine</italic>
<year>2011</year>
<volume>51</volume>
<issue>8</issue>
<fpage>1473</fpage>
<lpage>1479</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.07.007</pub-id>
<pub-id pub-id-type="other">2-s2.0-80052775577</pub-id>
<pub-id pub-id-type="pmid">21820047</pub-id>
</element-citation>
</ref>
<ref id="B49">
<label>49</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Chiou</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Chang</surname>
<given-names>P. Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J. T.</given-names>
</name>
</person-group>
<article-title>Urinary 8-OHdG: a marker of oxidative stress to DNA and a risk factor for cancer, atherosclerosis and diabetics</article-title>
<source/>
<italic toggle="yes">Clinica Chimica Acta</italic>
<year>2004</year>
<volume>339</volume>
<issue>1-2</issue>
<fpage>1</fpage>
<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.cccn.2003.09.010</pub-id>
<pub-id pub-id-type="other">2-s2.0-0345735389</pub-id>
</element-citation>
</ref>
<ref id="B50">
<label>50</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Foster</surname>
<given-names>M. W.</given-names>
</name>
<name>
<surname>McMahon</surname>
<given-names>T. J.</given-names>
</name>
<name>
<surname>Stamler</surname>
<given-names>J. S.</given-names>
</name>
</person-group>
<article-title>S-Nitrosylation in health and disease</article-title>
<source/>
<italic toggle="yes">Trends in Molecular Medicine</italic>
<year>2003</year>
<volume>9</volume>
<issue>4</issue>
<fpage>160</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.1016/S1471-4914(03)00028-5</pub-id>
<pub-id pub-id-type="other">2-s2.0-0038136867</pub-id>
<pub-id pub-id-type="pmid">12727142</pub-id>
</element-citation>
</ref>
<ref id="B51">
<label>51</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stadtman</surname>
<given-names>E. R.</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>R. L.</given-names>
</name>
</person-group>
<article-title>Free radical-mediated oxidation of free amino acids and amino acid residues in proteins</article-title>
<source/>
<italic toggle="yes">Amino Acids</italic>
<year>2003</year>
<volume>25</volume>
<issue>3-4</issue>
<fpage>207</fpage>
<lpage>218</lpage>
<pub-id pub-id-type="doi">10.1007/s00726-003-0011-2</pub-id>
<pub-id pub-id-type="other">2-s2.0-0346100345</pub-id>
<pub-id pub-id-type="pmid">14661084</pub-id>
</element-citation>
</ref>
<ref id="B52">
<label>52</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radi</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Oxygen radicals, nitric oxide, and peroxynitrite: redox pathways in molecular medicine</article-title>
<source/>
<italic toggle="yes">Proceedings of the National Academy of Sciences of the United States of America</italic>
<year>2018</year>
<volume>115</volume>
<issue>23</issue>
<fpage>5839</fpage>
<lpage>5848</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.1804932115</pub-id>
<pub-id pub-id-type="other">2-s2.0-85047990037</pub-id>
<pub-id pub-id-type="pmid">29802228</pub-id>
</element-citation>
</ref>
<ref id="B53">
<label>53</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kayama</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Raaz</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Jagger</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diabetic cardiovascular disease induced by oxidative stress</article-title>
<source/>
<italic toggle="yes">International Journal of Molecular Sciences</italic>
<year>2015</year>
<volume>16</volume>
<issue>10</issue>
<fpage>25234</fpage>
<lpage>25263</lpage>
<pub-id pub-id-type="doi">10.3390/ijms161025234</pub-id>
<pub-id pub-id-type="other">2-s2.0-84945270652</pub-id>
<pub-id pub-id-type="pmid">26512646</pub-id>
</element-citation>
</ref>
<ref id="B54">
<label>54</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rani</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Deep</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>R. K.</given-names>
</name>
<name>
<surname>Palle</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yadav</surname>
<given-names>U. C. S.</given-names>
</name>
</person-group>
<article-title>Oxidative stress and metabolic disorders: pathogenesis and therapeutic strategies</article-title>
<source/>
<italic toggle="yes">Life Sciences</italic>
<year>2016</year>
<volume>148</volume>
<fpage>183</fpage>
<lpage>193</lpage>
<pub-id pub-id-type="doi">10.1016/j.lfs.2016.02.002</pub-id>
<pub-id pub-id-type="other">2-s2.0-84959018825</pub-id>
<pub-id pub-id-type="pmid">26851532</pub-id>
</element-citation>
</ref>
<ref id="B55">
<label>55</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Korytár</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Molnárová</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sivonová</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Effects of aminoguanidine Schiff’s base on biomarkers of the oxidative stress, 4-hydroxy-2-nonenal and conjugated dienes, in the model diabetes mellitus</article-title>
<source/>
<italic toggle="yes">General Physiology and Biophysics</italic>
<year>2002</year>
<volume>21</volume>
<issue>3</issue>
<fpage>337</fpage>
<lpage>344</lpage>
<pub-id pub-id-type="pmid">12537356</pub-id>
</element-citation>
</ref>
<ref id="B56">
<label>56</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamagishi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Fukami</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Matsui</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Crosstalk between advanced glycation end products (AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications</article-title>
<source/>
<italic toggle="yes">Cardiovascular Diabetology</italic>
<year>2015</year>
<volume>14</volume>
<issue>1</issue>
<fpage>2</fpage>
<lpage>22</lpage>
<pub-id pub-id-type="doi">10.1186/s12933-015-0176-5</pub-id>
<pub-id pub-id-type="other">2-s2.0-84924328397</pub-id>
<pub-id pub-id-type="pmid">25582643</pub-id>
</element-citation>
</ref>
<ref id="B57">
<label>57</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamagishi</surname>
<given-names>S. I.</given-names>
</name>
<name>
<surname>Matsui</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Therapeutic potential of DNA-aptamers raised against AGE-RAGE axis in diabetes-related complications</article-title>
<source/>
<italic toggle="yes">Current Pharmaceutical Design</italic>
<year>2018</year>
<volume>24</volume>
<issue>24</issue>
<fpage>2802</fpage>
<lpage>2809</lpage>
<pub-id pub-id-type="doi">10.2174/1381612824666180829110124</pub-id>
<pub-id pub-id-type="other">2-s2.0-85056558315</pub-id>
<pub-id pub-id-type="pmid">30156152</pub-id>
</element-citation>
</ref>
<ref id="B58">
<label>58</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schober</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Chemokines in vascular dysfunction and remodeling</article-title>
<source/>
<italic toggle="yes">Arteriosclerosis, Thrombosis, and Vascular Biology</italic>
<year>2008</year>
<volume>28</volume>
<issue>11</issue>
<fpage>1950</fpage>
<lpage>1959</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.107.161224</pub-id>
<pub-id pub-id-type="other">2-s2.0-55449118234</pub-id>
</element-citation>
</ref>
<ref id="B59">
<label>59</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Holvoet</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kritchevsky</surname>
<given-names>S. B.</given-names>
</name>
<name>
<surname>Tracy</surname>
<given-names>R. P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort</article-title>
<source/>
<italic toggle="yes">Diabetes</italic>
<year>2004</year>
<volume>53</volume>
<issue>4</issue>
<fpage>1068</fpage>
<lpage>1073</lpage>
<pub-id pub-id-type="doi">10.2337/diabetes.53.4.1068</pub-id>
<pub-id pub-id-type="other">2-s2.0-1842527452</pub-id>
<pub-id pub-id-type="pmid">15047623</pub-id>
</element-citation>
</ref>
<ref id="B60">
<label>60</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szabo</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Role of nitrosative stress in the pathogenesis of diabetic vascular dysfunction</article-title>
<source/>
<italic toggle="yes">British Journal of Pharmacology</italic>
<year>2009</year>
<volume>156</volume>
<issue>5</issue>
<fpage>713</fpage>
<lpage>727</lpage>
<pub-id pub-id-type="doi">10.1111/j.1476-5381.2008.00086.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-64149103180</pub-id>
<pub-id pub-id-type="pmid">19210748</pub-id>
</element-citation>
</ref>
<ref id="B61">
<label>61</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen</surname>
<given-names>R. A.</given-names>
</name>
</person-group>
<article-title>Role of nitric oxide in diabetic complications</article-title>
<source/>
<italic toggle="yes">American Journal of Therapeutics</italic>
<year>2005</year>
<volume>12</volume>
<issue>6</issue>
<fpage>499</fpage>
<lpage>502</lpage>
<pub-id pub-id-type="doi">10.1097/01.mjt.0000178776.77267.19</pub-id>
<pub-id pub-id-type="other">2-s2.0-28044432087</pub-id>
<pub-id pub-id-type="pmid">16280643</pub-id>
</element-citation>
</ref>
<ref id="B62">
<label>62</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>G. X.</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction, oxidative stress and diabetic cardiovascular disorders</article-title>
<source/>
<italic toggle="yes">Cardiovascular &amp; Hematological Disorders-Drug Targets</italic>
<year>2012</year>
<volume>12</volume>
<issue>2</issue>
<fpage>106</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="doi">10.2174/1871529X11202020106</pub-id>
<pub-id pub-id-type="other">2-s2.0-84873390601</pub-id>
<pub-id pub-id-type="pmid">23030449</pub-id>
</element-citation>
</ref>
<ref id="B63">
<label>63</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stefano</surname>
<given-names>G. B.</given-names>
</name>
<name>
<surname>Challenger</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kream</surname>
<given-names>R. M.</given-names>
</name>
</person-group>
<article-title>Hyperglycemia-associated alterations in cellular signaling and dysregulated mitochondrial bioenergetics in human metabolic disorders</article-title>
<source/>
<italic toggle="yes">European Journal of Nutrition</italic>
<year>2016</year>
<volume>55</volume>
<issue>8</issue>
<fpage>2339</fpage>
<lpage>2345</lpage>
<pub-id pub-id-type="doi">10.1007/s00394-016-1212-2</pub-id>
<pub-id pub-id-type="other">2-s2.0-84963737960</pub-id>
<pub-id pub-id-type="pmid">27084094</pub-id>
</element-citation>
</ref>
<ref id="B64">
<label>64</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haffner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Taegtmeyer</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Epidemic obesity and the metabolic syndrome</article-title>
<source/>
<italic toggle="yes">Circulation</italic>
<year>2003</year>
<volume>108</volume>
<issue>13</issue>
<fpage>1541</fpage>
<lpage>1545</lpage>
<pub-id pub-id-type="doi">10.1161/01.CIR.0000088845.17586.EC</pub-id>
<pub-id pub-id-type="other">2-s2.0-0141506880</pub-id>
<pub-id pub-id-type="pmid">14517149</pub-id>
</element-citation>
</ref>
<ref id="B65">
<label>65</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Matsuda</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shimomura</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer</article-title>
<source/>
<italic toggle="yes">Obesity Research &amp; Clinical Practice</italic>
<year>2013</year>
<volume>7</volume>
<issue>5</issue>
<fpage>330</fpage>
<lpage>341</lpage>
</element-citation>
</ref>
<ref id="B66">
<label>66</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Otani</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Oxidative stress as pathogenesis of cardiovascular risk associated with metabolic syndrome</article-title>
<source/>
<italic toggle="yes">Antioxidants &amp; Redox Signaling</italic>
<year>2011</year>
<volume>15</volume>
<issue>7</issue>
<fpage>1911</fpage>
<lpage>1926</lpage>
<pub-id pub-id-type="doi">10.1089/ars.2010.3739</pub-id>
<pub-id pub-id-type="other">2-s2.0-80051993151</pub-id>
<pub-id pub-id-type="pmid">21126197</pub-id>
</element-citation>
</ref>
<ref id="B67">
<label>67</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Augé</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Maupas-Schwalm</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Elbaz</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein–induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation</article-title>
<source/>
<italic toggle="yes">Circulation</italic>
<year>2004</year>
<volume>110</volume>
<issue>5</issue>
<fpage>571</fpage>
<lpage>578</lpage>
<pub-id pub-id-type="doi">10.1161/01.CIR.0000136995.83451.1D</pub-id>
<pub-id pub-id-type="other">2-s2.0-3543141882</pub-id>
<pub-id pub-id-type="pmid">15277330</pub-id>
</element-citation>
</ref>
<ref id="B68">
<label>68</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Puddu</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Puddu</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Galletti</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Cravero</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Muscari</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis</article-title>
<source/>
<italic toggle="yes">Cardiology</italic>
<year>2005</year>
<volume>103</volume>
<issue>3</issue>
<fpage>137</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="doi">10.1159/000083440</pub-id>
<pub-id pub-id-type="other">2-s2.0-21744434763</pub-id>
<pub-id pub-id-type="pmid">15665536</pub-id>
</element-citation>
</ref>
<ref id="B69">
<label>69</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anderson</surname>
<given-names>E. J.</given-names>
</name>
<name>
<surname>Lustig</surname>
<given-names>M. E.</given-names>
</name>
<name>
<surname>Boyle</surname>
<given-names>K. E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial H<sub>2</sub>O<sub>2</sub> emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans</article-title>
<source/>
<italic toggle="yes">The Journal of Clinical Investigation</italic>
<year>2009</year>
<volume>119</volume>
<issue>3</issue>
<fpage>573</fpage>
<lpage>581</lpage>
<pub-id pub-id-type="doi">10.1172/JCI37048</pub-id>
<pub-id pub-id-type="other">2-s2.0-67650815430</pub-id>
<pub-id pub-id-type="pmid">19188683</pub-id>
</element-citation>
</ref>
<ref id="B70">
<label>70</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roy Chowdhury</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Sangle</surname>
<given-names>G. V.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Stelmack</surname>
<given-names>G. L.</given-names>
</name>
<name>
<surname>Halayko</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>G. X.</given-names>
</name>
</person-group>
<article-title>Effects of extensively oxidized low-density lipoprotein on mitochondrial function and reactive oxygen species in porcine aortic endothelial cells</article-title>
<source/>
<italic toggle="yes">American Journal of Physiology-Endocrinology and Metabolism</italic>
<year>2010</year>
<volume>298</volume>
<issue>1</issue>
<fpage>E89</fpage>
<lpage>E98</lpage>
<pub-id pub-id-type="doi">10.1152/ajpendo.00433.2009</pub-id>
<pub-id pub-id-type="other">2-s2.0-73649108218</pub-id>
<pub-id pub-id-type="pmid">19843872</pub-id>
</element-citation>
</ref>
<ref id="B71">
<label>71</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chattopadhyay</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Khemka</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Chatterjee</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ganguly</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Mukhopadhyay</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Chakrabarti</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Enhanced ROS production and oxidative damage in subcutaneous white adipose tissue mitochondria in obese and type 2 diabetes subjects</article-title>
<source/>
<italic toggle="yes">Molecular and Cellular Biochemistry</italic>
<year>2015</year>
<volume>399</volume>
<issue>1-2</issue>
<fpage>95</fpage>
<lpage>103</lpage>
<pub-id pub-id-type="doi">10.1007/s11010-014-2236-7</pub-id>
<pub-id pub-id-type="other">2-s2.0-84916929446</pub-id>
<pub-id pub-id-type="pmid">25312902</pub-id>
</element-citation>
</ref>
<ref id="B72">
<label>72</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Akoumianakis</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Antoniades</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>Impaired vascular redox signaling in the vascular complications of obesity and diabetes mellitus</article-title>
<source/>
<italic toggle="yes">Antioxidants &amp; Redox Signaling</italic>
<year>2018</year>
<volume>30</volume>
<issue>3</issue>
<fpage>333</fpage>
<lpage>353</lpage>
<pub-id pub-id-type="doi">10.1089/ars.2017.7421</pub-id>
<pub-id pub-id-type="other">2-s2.0-85051943861</pub-id>
</element-citation>
</ref>
<ref id="B73">
<label>73</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esser</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Legrand-Poels</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Piette</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Scheen</surname>
<given-names>A. J.</given-names>
</name>
<name>
<surname>Paquot</surname>
<given-names>N.</given-names>
</name>
</person-group>
<article-title>Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes</article-title>
<source/>
<italic toggle="yes">Diabetes Research and Clinical Practice</italic>
<year>2014</year>
<volume>105</volume>
<issue>2</issue>
<fpage>141</fpage>
<lpage>150</lpage>
<pub-id pub-id-type="doi">10.1016/j.diabres.2014.04.006</pub-id>
<pub-id pub-id-type="other">2-s2.0-84906055605</pub-id>
<pub-id pub-id-type="pmid">24798950</pub-id>
</element-citation>
</ref>
<ref id="B74">
<label>74</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bonomini</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rodella</surname>
<given-names>L. F.</given-names>
</name>
<name>
<surname>Rezzani</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Metabolic syndrome, aging and involvement of oxidative stress</article-title>
<source/>
<italic toggle="yes">Aging and Disease</italic>
<year>2015</year>
<volume>6</volume>
<issue>2</issue>
<fpage>109</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="doi">10.1038/nature04634</pub-id>
<pub-id pub-id-type="other">2-s2.0-33645860825</pub-id>
<pub-id pub-id-type="pmid">25821639</pub-id>
</element-citation>
</ref>
<ref id="B75">
<label>75</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bostan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yildiz</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ozkan</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Uzunhasan</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kaya</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Yigit</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Beneficial effects of rosuvastatin treatment in patients with metabolic syndrome</article-title>
<source/>
<italic toggle="yes">Angiology</italic>
<year>2015</year>
<volume>66</volume>
<issue>2</issue>
<fpage>122</fpage>
<lpage>127</lpage>
<pub-id pub-id-type="doi">10.1177/0003319714522107</pub-id>
<pub-id pub-id-type="other">2-s2.0-84925581666</pub-id>
<pub-id pub-id-type="pmid">24554427</pub-id>
</element-citation>
</ref>
<ref id="B76">
<label>76</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lassègue</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Griendling</surname>
<given-names>K. K.</given-names>
</name>
</person-group>
<article-title>NADPH oxidases: functions and pathologies in the vasculature</article-title>
<source/>
<italic toggle="yes">Arteriosclerosis, Thrombosis, and Vascular Biology</italic>
<year>2010</year>
<volume>30</volume>
<issue>4</issue>
<fpage>653</fpage>
<lpage>661</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.108.181610</pub-id>
<pub-id pub-id-type="other">2-s2.0-77950896739</pub-id>
<pub-id pub-id-type="pmid">19910640</pub-id>
</element-citation>
</ref>
<ref id="B77">
<label>77</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brasier</surname>
<given-names>A. R.</given-names>
</name>
<name>
<surname>Recinos</surname>
<given-names>A.</given-names>
<suffix>III</suffix>
</name>
<name>
<surname>Eledrisi</surname>
<given-names>M. S.</given-names>
</name>
</person-group>
<article-title>Vascular inflammation and the renin-angiotensin system</article-title>
<source/>
<italic toggle="yes">Arteriosclerosis, Thrombosis, and Vascular Biology</italic>
<year>2002</year>
<volume>22</volume>
<issue>8</issue>
<fpage>1257</fpage>
<lpage>1266</lpage>
<pub-id pub-id-type="doi">10.1161/01.ATV.0000021412.56621.A2</pub-id>
<pub-id pub-id-type="other">2-s2.0-0036347258</pub-id>
</element-citation>
</ref>
<ref id="B78">
<label>78</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Teshima</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Nishio</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Production of reactive oxygen species in the diabetic heart: roles of mitochondria and NADPH oxidase</article-title>
<source/>
<italic toggle="yes">Circulation Journal</italic>
<year>2014</year>
<volume>78</volume>
<issue>2</issue>
<fpage>300</fpage>
<lpage>306</lpage>
<pub-id pub-id-type="doi">10.1253/circj.CJ-13-1187</pub-id>
<pub-id pub-id-type="other">2-s2.0-84892952980</pub-id>
<pub-id pub-id-type="pmid">24334638</pub-id>
</element-citation>
</ref>
<ref id="B79">
<label>79</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Youn</surname>
<given-names>J.-Y.</given-names>
</name>
<name>
<surname>Siu</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Lob</surname>
<given-names>H. E.</given-names>
</name>
<name>
<surname>Itani</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Role of vascular oxidative stress in obesity and metabolic syndrome</article-title>
<source/>
<italic toggle="yes">Diabetes</italic>
<year>2014</year>
<volume>63</volume>
<issue>7</issue>
<fpage>2344</fpage>
<lpage>2355</lpage>
<pub-id pub-id-type="doi">10.2337/db13-0719</pub-id>
<pub-id pub-id-type="other">2-s2.0-84903177300</pub-id>
<pub-id pub-id-type="pmid">24550188</pub-id>
</element-citation>
</ref>
<ref id="B80">
<label>80</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Horke</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Forstermann</surname>
<given-names>U.</given-names>
</name>
</person-group>
<article-title>Oxidative stress in vascular disease and its pharmacological prevention</article-title>
<source/>
<italic toggle="yes">Trends in Pharmacological Sciences</italic>
<year>2013</year>
<volume>34</volume>
<issue>6</issue>
<fpage>313</fpage>
<lpage>319</lpage>
<pub-id pub-id-type="doi">10.1016/j.tips.2013.03.007</pub-id>
<pub-id pub-id-type="other">2-s2.0-84878525986</pub-id>
<pub-id pub-id-type="pmid">23608227</pub-id>
</element-citation>
</ref>
<ref id="B81">
<label>81</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dikalov</surname>
<given-names>S.</given-names>
</name>
</person-group>
<article-title>Cross talk between mitochondria and NADPH oxidases</article-title>
<source/>
<italic toggle="yes">Free Radical Biology &amp; Medicine</italic>
<year>2011</year>
<volume>51</volume>
<issue>7</issue>
<fpage>1289</fpage>
<lpage>1301</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.06.033</pub-id>
<pub-id pub-id-type="other">2-s2.0-80052266526</pub-id>
<pub-id pub-id-type="pmid">21777669</pub-id>
</element-citation>
</ref>
<ref id="B82">
<label>82</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rask-Madsen</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>King</surname>
<given-names>G. L.</given-names>
</name>
</person-group>
<article-title>Vascular complications of diabetes: mechanisms of injury and protective factors</article-title>
<source/>
<italic toggle="yes">Cell Metabolism</italic>
<year>2013</year>
<volume>17</volume>
<issue>1</issue>
<fpage>20</fpage>
<lpage>33</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2012.11.012</pub-id>
<pub-id pub-id-type="other">2-s2.0-84872158502</pub-id>
<pub-id pub-id-type="pmid">23312281</pub-id>
</element-citation>
</ref>
<ref id="B83">
<label>83</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>J.-M.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>A. M.</given-names>
</name>
</person-group>
<article-title>ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy</article-title>
<source/>
<italic toggle="yes">Journal of the American Society of Nephrology</italic>
<year>2003</year>
<volume>14</volume>
<issue>Supplement 3</issue>
<fpage>221S</fpage>
<lpage>2226</lpage>
<pub-id pub-id-type="doi">10.1097/01.ASN.0000077406.67663.E7</pub-id>
</element-citation>
</ref>
<ref id="B84">
<label>84</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sangle</surname>
<given-names>G. V.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mizuno</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>G. X.</given-names>
</name>
</person-group>
<article-title>Involvement of RAGE, NADPH oxidase, and Ras/Raf-1 pathway in glycated LDL-induced expression of heat shock factor-1 and plasminogen activator inhibitor-1 in vascular endothelial cells</article-title>
<source/>
<italic toggle="yes">Endocrinology</italic>
<year>2010</year>
<volume>151</volume>
<issue>9</issue>
<fpage>4455</fpage>
<lpage>4466</lpage>
<pub-id pub-id-type="doi">10.1210/en.2010-0323</pub-id>
<pub-id pub-id-type="other">2-s2.0-77956028829</pub-id>
<pub-id pub-id-type="pmid">20630999</pub-id>
</element-citation>
</ref>
<ref id="B85">
<label>85</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inoguchi</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Umeda</surname>
<given-names>F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells</article-title>
<source/>
<italic toggle="yes">Diabetes</italic>
<year>2000</year>
<volume>49</volume>
<issue>11</issue>
<fpage>1939</fpage>
<lpage>1945</lpage>
<pub-id pub-id-type="doi">10.2337/diabetes.49.11.1939</pub-id>
<pub-id pub-id-type="other">2-s2.0-0033765672</pub-id>
<pub-id pub-id-type="pmid">11078463</pub-id>
</element-citation>
</ref>
<ref id="B86">
<label>86</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ding</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Aljofan</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Triggle</surname>
<given-names>C. R.</given-names>
</name>
</person-group>
<article-title>Oxidative stress and increased eNOS and NADPH oxidase expression in mouse microvessel endothelial cells</article-title>
<source/>
<italic toggle="yes">Journal of Cellular Physiology</italic>
<year>2007</year>
<volume>212</volume>
<issue>3</issue>
<fpage>682</fpage>
<lpage>689</lpage>
<pub-id pub-id-type="doi">10.1002/jcp.21063</pub-id>
<pub-id pub-id-type="other">2-s2.0-34547946423</pub-id>
<pub-id pub-id-type="pmid">17443690</pub-id>
</element-citation>
</ref>
<ref id="B87">
<label>87</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Doughan</surname>
<given-names>A. K.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>D. G.</given-names>
</name>
<name>
<surname>Dikalov</surname>
<given-names>S. I.</given-names>
</name>
</person-group>
<article-title>Molecular mechanisms of angiotensin II–mediated mitochondrial dysfunction: Linking mitochondrial oxidative damage and vascular endothelial dysfunction</article-title>
<source/>
<italic toggle="yes">Circulation Research</italic>
<year>2008</year>
<volume>102</volume>
<issue>4</issue>
<fpage>488</fpage>
<lpage>496</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.107.162800</pub-id>
<pub-id pub-id-type="other">2-s2.0-41949104144</pub-id>
<pub-id pub-id-type="pmid">18096818</pub-id>
</element-citation>
</ref>
<ref id="B88">
<label>88</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Privratsky</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Wold</surname>
<given-names>L. E.</given-names>
</name>
<name>
<surname>Sowers</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Quinn</surname>
<given-names>M. T.</given-names>
</name>
<name>
<surname>Ren</surname>
<given-names>J.</given-names>
</name>
</person-group>
<article-title>AT<sub>1</sub> blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes</article-title>
<source/>
<italic toggle="yes">Hypertension</italic>
<year>2003</year>
<volume>42</volume>
<issue>2</issue>
<fpage>206</fpage>
<lpage>212</lpage>
<pub-id pub-id-type="doi">10.1161/01.HYP.0000082814.62655.85</pub-id>
<pub-id pub-id-type="other">2-s2.0-0042266230</pub-id>
<pub-id pub-id-type="pmid">12847113</pub-id>
</element-citation>
</ref>
<ref id="B89">
<label>89</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wei</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zavilowitz</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Satlin</surname>
<given-names>L. M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>W. H.</given-names>
</name>
</person-group>
<article-title>Angiotensin II inhibits the ROMK-like small conductance K channel in renal cortical collecting duct during dietary potassium restriction</article-title>
<source/>
<italic toggle="yes">The Journal of Biological Chemistry</italic>
<year>2007</year>
<volume>282</volume>
<issue>9</issue>
<fpage>6455</fpage>
<lpage>6462</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M607477200</pub-id>
<pub-id pub-id-type="other">2-s2.0-34250379991</pub-id>
<pub-id pub-id-type="pmid">17194699</pub-id>
</element-citation>
</ref>
<ref id="B90">
<label>90</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brownlee</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Biochemistry and molecular cell biology of diabetic complications</article-title>
<source/>
<italic toggle="yes">Nature</italic>
<year>2001</year>
<volume>414</volume>
<issue>6865</issue>
<fpage>813</fpage>
<lpage>820</lpage>
<pub-id pub-id-type="doi">10.1038/414813a</pub-id>
<pub-id pub-id-type="other">2-s2.0-0035856980</pub-id>
<pub-id pub-id-type="pmid">11742414</pub-id>
</element-citation>
</ref>
<ref id="B91">
<label>91</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wautier</surname>
<given-names>M.-P.</given-names>
</name>
<name>
<surname>Chappey</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Corda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Schmidt</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Wautier</surname>
<given-names>J.-L.</given-names>
</name>
</person-group>
<article-title>Activation of NADPH oxidase by AGE links oxidant stress to altered gene expression via RAGE</article-title>
<source/>
<italic toggle="yes">American Journal of Physiology-Endocrinology and Metabolism</italic>
<year>2001</year>
<volume>280</volume>
<issue>5</issue>
<fpage>E685</fpage>
<lpage>E694</lpage>
<pub-id pub-id-type="doi">10.1152/ajpendo.2001.280.5.E685</pub-id>
<pub-id pub-id-type="pmid">11287350</pub-id>
</element-citation>
</ref>
<ref id="B92">
<label>92</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Csiszar</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ungvari</surname>
<given-names>Z.</given-names>
</name>
</person-group>
<article-title>Endothelial dysfunction and vascular inflammation in type 2 diabetes: interaction of AGE/RAGE and TNF-<italic>α</italic> signaling</article-title>
<source/>
<italic toggle="yes">American Journal of Physiology-Heart and Circulatory Physiology</italic>
<year>2008</year>
<volume>295</volume>
<issue>2</issue>
<fpage>H475</fpage>
<lpage>H476</lpage>
<pub-id pub-id-type="doi">10.1152/ajpheart.00644.2008</pub-id>
<pub-id pub-id-type="other">2-s2.0-52449105457</pub-id>
<pub-id pub-id-type="pmid">18599592</pub-id>
</element-citation>
</ref>
<ref id="B93">
<label>93</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tirziu</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Simons</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Endothelium-driven myocardial growth or nitric oxide at the crossroads</article-title>
<source/>
<italic toggle="yes">Trends in Cardiovascular Medicine</italic>
<year>2008</year>
<volume>18</volume>
<issue>8</issue>
<fpage>299</fpage>
<lpage>305</lpage>
<pub-id pub-id-type="doi">10.1016/j.tcm.2009.01.002</pub-id>
<pub-id pub-id-type="other">2-s2.0-63249131125</pub-id>
<pub-id pub-id-type="pmid">19345317</pub-id>
</element-citation>
</ref>
<ref id="B94">
<label>94</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pechánová</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>Z. V.</given-names>
</name>
<name>
<surname>Cebová</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Giricz</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Pacher</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Ferdinandy</surname>
<given-names>P.</given-names>
</name>
</person-group>
<article-title>Cardiac NO signalling in the metabolic syndrome</article-title>
<source/>
<italic toggle="yes">British Journal of Pharmacology</italic>
<year>2015</year>
<volume>172</volume>
<issue>6</issue>
<fpage>1415</fpage>
<lpage>1433</lpage>
<pub-id pub-id-type="doi">10.1111/bph.12960</pub-id>
<pub-id pub-id-type="other">2-s2.0-84923781545</pub-id>
<pub-id pub-id-type="pmid">25297560</pub-id>
</element-citation>
</ref>
<ref id="B95">
<label>95</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jesmin</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Zaedi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Maeda</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yamaguchi</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Goto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Miyauchi</surname>
<given-names>T.</given-names>
</name>
</person-group>
<article-title>Effects of a selective endothelin a receptor antagonist on the expressions of iNOS and eNOS in the heart of early streptozotocin-induced diabetic rats</article-title>
<source/>
<italic toggle="yes">Experimental Biology and Medicine</italic>
<year>2006</year>
<volume>231</volume>
<issue>6</issue>
<fpage>925</fpage>
<lpage>931</lpage>
<pub-id pub-id-type="pmid">16741025</pub-id>
</element-citation>
</ref>
<ref id="B96">
<label>96</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ilkun</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Wilde</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Tuinei</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Antioxidant treatment normalizes mitochondrial energetics and myocardial insulin sensitivity independently of changes in systemic metabolic homeostasis in a mouse model of the metabolic syndrome</article-title>
<source/>
<italic toggle="yes">Journal of Molecular and Cellular Cardiology</italic>
<year>2015</year>
<volume>85</volume>
<fpage>104</fpage>
<lpage>116</lpage>
<pub-id pub-id-type="doi">10.1016/j.yjmcc.2015.05.012</pub-id>
<pub-id pub-id-type="other">2-s2.0-84930622841</pub-id>
<pub-id pub-id-type="pmid">26004364</pub-id>
</element-citation>
</ref>
<ref id="B97">
<label>97</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mootha</surname>
<given-names>V. K.</given-names>
</name>
<name>
<surname>Bunkenborg</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Olsen</surname>
<given-names>J. V.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Integrated analysis of protein composition, tissue diversity, and gene regulation in mouse mitochondria</article-title>
<source/>
<italic toggle="yes">Cell</italic>
<year>2003</year>
<volume>115</volume>
<issue>5</issue>
<fpage>629</fpage>
<lpage>640</lpage>
<pub-id pub-id-type="doi">10.1016/S0092-8674(03)00926-7</pub-id>
<pub-id pub-id-type="other">2-s2.0-10744224439</pub-id>
<pub-id pub-id-type="pmid">14651853</pub-id>
</element-citation>
</ref>
<ref id="B98">
<label>98</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shen</surname>
<given-names>X. C.</given-names>
</name>
<name>
<surname>Tao</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W. K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y. Y.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Y. Y.</given-names>
</name>
</person-group>
<article-title>Evidence-based antioxidant activity of the essential oil from Fructus A. zerumbet on cultured human umbilical vein endothelial cells’ injury induced by ox-LDL</article-title>
<source/>
<italic toggle="yes">BMC Complementary and Alternative Medicine</italic>
<year>2012</year>
<volume>12</volume>
<issue>1</issue>
<fpage>p. 174</fpage>
<pub-id pub-id-type="doi">10.1186/1472-6882-12-174</pub-id>
<pub-id pub-id-type="other">2-s2.0-84867023609</pub-id>
<pub-id pub-id-type="pmid">23039037</pub-id>
</element-citation>
</ref>
<ref id="B99">
<label>99</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Joseph</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Adhihetty</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Buford</surname>
<given-names>T. W.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The impact of aging on mitochondrial function and biogenesis pathways in skeletal muscle of sedentary high- and low-functioning elderly individuals</article-title>
<source/>
<italic toggle="yes">Aging Cell</italic>
<year>2012</year>
<volume>11</volume>
<issue>5</issue>
<fpage>801</fpage>
<lpage>809</lpage>
<pub-id pub-id-type="doi">10.1111/j.1474-9726.2012.00844.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-84866444702</pub-id>
<pub-id pub-id-type="pmid">22681576</pub-id>
</element-citation>
</ref>
<ref id="B100">
<label>100</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kay</surname>
<given-names>A. M.</given-names>
</name>
<name>
<surname>Simpson</surname>
<given-names>C. L. S.</given-names>
</name>
<name>
<surname>Stewart</surname>
<given-names>J. A.</given-names>
</name>
</person-group>
<article-title>The role of AGE/RAGE signaling in diabetes-mediated vascular calcification</article-title>
<source/>
<italic toggle="yes">Journal of Diabetes Research</italic>
<year>2016</year>
<volume>2016</volume>
<fpage>8</fpage>
<pub-id pub-id-type="publisher-id">6809703</pub-id>
<pub-id pub-id-type="doi">10.1155/2016/6809703</pub-id>
<pub-id pub-id-type="other">2-s2.0-84982113299</pub-id>
</element-citation>
</ref>
<ref id="B101">
<label>101</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Straface</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Gambardella</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Mattatelli</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The red blood cell as a gender-associated biomarker in metabolic syndrome: a pilot study</article-title>
<source/>
<italic toggle="yes">International Journal of Cell Biology</italic>
<year>2011</year>
<volume>2011</volume>
<fpage>7</fpage>
<pub-id pub-id-type="publisher-id">204157</pub-id>
<pub-id pub-id-type="doi">10.1155/2011/204157</pub-id>
<pub-id pub-id-type="other">2-s2.0-81555220056</pub-id>
</element-citation>
</ref>
<ref id="B102">
<label>102</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berliner</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Rogowski</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Aharonov</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Erythrocyte adhesiveness/aggregation: a novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease</article-title>
<source/>
<italic toggle="yes">American Heart Journal</italic>
<year>2005</year>
<volume>149</volume>
<issue>2</issue>
<fpage>260</fpage>
<lpage>267</lpage>
<pub-id pub-id-type="doi">10.1016/j.ahj.2004.05.058</pub-id>
<pub-id pub-id-type="other">2-s2.0-20044368974</pub-id>
<pub-id pub-id-type="pmid">15846263</pub-id>
</element-citation>
</ref>
<ref id="B103">
<label>103</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Straface</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Rivabene</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Masella</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Santulli</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Paganelli</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Malorni</surname>
<given-names>W.</given-names>
</name>
</person-group>
<article-title>Structural changes of the erythrocyte as a marker of non-insulin-dependent diabetes: protective effects of N-acetylcysteine</article-title>
<source/>
<italic toggle="yes">Biochemical and Biophysical Research Communications</italic>
<year>2002</year>
<volume>290</volume>
<issue>5</issue>
<fpage>1393</fpage>
<lpage>1398</lpage>
<pub-id pub-id-type="doi">10.1006/bbrc.2002.6340</pub-id>
<pub-id pub-id-type="other">2-s2.0-0036298194</pub-id>
<pub-id pub-id-type="pmid">11820776</pub-id>
</element-citation>
</ref>
<ref id="B104">
<label>104</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhai</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Impact of nutritional and environmental factors on inflammation, oxidative stress, and the microbiome</article-title>
<source/>
<italic toggle="yes">BioMed Research International</italic>
<year>2018</year>
<volume>2018</volume>
<fpage>3</fpage>
<pub-id pub-id-type="publisher-id">5606845</pub-id>
<pub-id pub-id-type="doi">10.1155/2018/5606845</pub-id>
<pub-id pub-id-type="other">2-s2.0-85051572617</pub-id>
</element-citation>
</ref>
<ref id="B105">
<label>105</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bray</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Lovejoy</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>S. R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The influence of different fats and fatty acids on obesity, insulin resistance and inflammation</article-title>
<source/>
<italic toggle="yes">The Journal of Nutrition</italic>
<year>2002</year>
<volume>132</volume>
<issue>9</issue>
<fpage>2488</fpage>
<lpage>2491</lpage>
<pub-id pub-id-type="doi">10.1093/jn/132.9.2488</pub-id>
<pub-id pub-id-type="pmid">12221198</pub-id>
</element-citation>
</ref>
<ref id="B106">
<label>106</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buettner</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Schölmerich</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Bollheimer</surname>
<given-names>L. C.</given-names>
</name>
</person-group>
<article-title>High-fat diets: modeling the metabolic disorders of human obesity in rodents</article-title>
<source/>
<italic toggle="yes">Obesity</italic>
<year>2007</year>
<volume>15</volume>
<issue>4</issue>
<fpage>798</fpage>
<lpage>808</lpage>
<pub-id pub-id-type="doi">10.1038/oby.2007.608</pub-id>
<pub-id pub-id-type="other">2-s2.0-34248393099</pub-id>
<pub-id pub-id-type="pmid">17426312</pub-id>
</element-citation>
</ref>
<ref id="B107">
<label>107</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanhope</surname>
<given-names>K. L.</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Keim</surname>
<given-names>N. L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans</article-title>
<source/>
<italic toggle="yes">The Journal of Clinical Investigation</italic>
<year>2009</year>
<volume>119</volume>
<issue>5</issue>
<fpage>1322</fpage>
<lpage>1334</lpage>
<pub-id pub-id-type="doi">10.1172/JCI37385</pub-id>
<pub-id pub-id-type="other">2-s2.0-66449093225</pub-id>
<pub-id pub-id-type="pmid">19381015</pub-id>
</element-citation>
</ref>
<ref id="B108">
<label>108</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aller</surname>
<given-names>E. E. J. G.</given-names>
</name>
<name>
<surname>Abete</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Astrup</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Martinez</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Baak</surname>
<given-names>M. A. v.</given-names>
</name>
</person-group>
<article-title>Starches, sugars and obesity</article-title>
<source/>
<italic toggle="yes">Nutrients</italic>
<year>2011</year>
<volume>3</volume>
<issue>3</issue>
<fpage>341</fpage>
<lpage>369</lpage>
<pub-id pub-id-type="doi">10.3390/nu3030341</pub-id>
<pub-id pub-id-type="other">2-s2.0-79953674813</pub-id>
<pub-id pub-id-type="pmid">22254101</pub-id>
</element-citation>
</ref>
<ref id="B109">
<label>109</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Velasquez</surname>
<given-names>M. T.</given-names>
</name>
</person-group>
<article-title>Altered gut microbiota: a link between diet and the metabolic syndrome</article-title>
<source/>
<italic toggle="yes">Metabolic Syndrome and Related Disorders</italic>
<year>2018</year>
<volume>16</volume>
<issue>7</issue>
<fpage>321</fpage>
<lpage>328</lpage>
<pub-id pub-id-type="doi">10.1089/met.2017.0163</pub-id>
<pub-id pub-id-type="other">2-s2.0-85052911292</pub-id>
<pub-id pub-id-type="pmid">29957105</pub-id>
</element-citation>
</ref>
<ref id="B110">
<label>110</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ley</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J. I.</given-names>
</name>
</person-group>
<article-title>Ecological and evolutionary forces shaping microbial diversity in the human intestine</article-title>
<source/>
<italic toggle="yes">Cell</italic>
<year>2006</year>
<volume>124</volume>
<issue>4</issue>
<fpage>837</fpage>
<lpage>848</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2006.02.017</pub-id>
<pub-id pub-id-type="other">2-s2.0-32944466887</pub-id>
<pub-id pub-id-type="pmid">16497592</pub-id>
</element-citation>
</ref>
<ref id="B111">
<label>111</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Eckburg</surname>
<given-names>P. B.</given-names>
</name>
<name>
<surname>Bik</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>C. N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diversity of the human intestinal microbial flora</article-title>
<source/>
<italic toggle="yes">Science</italic>
<year>2005</year>
<volume>308</volume>
<issue>5728</issue>
<fpage>1635</fpage>
<lpage>1638</lpage>
<pub-id pub-id-type="doi">10.1126/science.1110591</pub-id>
<pub-id pub-id-type="other">2-s2.0-20544444045</pub-id>
<pub-id pub-id-type="pmid">15831718</pub-id>
</element-citation>
</ref>
<ref id="B112">
<label>112</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hammond</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Levine</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>The economic impact of obesity in the United States</article-title>
<source/>
<italic toggle="yes">Diabetes, Metabolic Syndrome and Obesity</italic>
<year>2010</year>
<volume>3</volume>
<fpage>285</fpage>
<lpage>295</lpage>
<pub-id pub-id-type="doi">10.2147/DMSO.S7384</pub-id>
</element-citation>
</ref>
<ref id="B113">
<label>113</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ferrarese</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Ceresola</surname>
<given-names>E. R.</given-names>
</name>
<name>
<surname>Preti</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Canducci</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Probiotics, prebiotics and synbiotics for weight loss and metabolic syndrome in the microbiome era</article-title>
<source/>
<italic toggle="yes">European Review for Medical and Pharmacological Sciences</italic>
<year>2018</year>
<volume>22</volume>
<issue>21</issue>
<fpage>7588</fpage>
<lpage>7605</lpage>
<pub-id pub-id-type="pmid">30468509</pub-id>
</element-citation>
</ref>
<ref id="B114">
<label>114</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgen</surname>
<given-names>C. S.</given-names>
</name>
<name>
<surname>Sørensen</surname>
<given-names>T. I. A.</given-names>
</name>
</person-group>
<article-title>Obesity: global trends in the prevalence of overweight and obesity</article-title>
<source/>
<italic toggle="yes">Nature Reviews Endocrinology</italic>
<year>2014</year>
<volume>10</volume>
<issue>9</issue>
<fpage>513</fpage>
<lpage>514</lpage>
<pub-id pub-id-type="doi">10.1038/nrendo.2014.124</pub-id>
<pub-id pub-id-type="other">2-s2.0-84906790594</pub-id>
<pub-id pub-id-type="pmid">25048038</pub-id>
</element-citation>
</ref>
<ref id="B115">
<label>115</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sekirov</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Russell</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Antunes</surname>
<given-names>L. C. M.</given-names>
</name>
<name>
<surname>Finlay</surname>
<given-names>B. B.</given-names>
</name>
</person-group>
<article-title>Gut microbiota in health and disease</article-title>
<source/>
<italic toggle="yes">Physiological Reviews</italic>
<year>2010</year>
<volume>90</volume>
<issue>3</issue>
<fpage>859</fpage>
<lpage>904</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00045.2009</pub-id>
<pub-id pub-id-type="other">2-s2.0-77955647582</pub-id>
<pub-id pub-id-type="pmid">20664075</pub-id>
</element-citation>
</ref>
<ref id="B116">
<label>116</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nallu</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ramezani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Muralidharan</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Raj</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Gut microbiome in chronic kidney disease: challenges and opportunities</article-title>
<source/>
<italic toggle="yes">Translational Research</italic>
<year>2017</year>
<volume>179</volume>
<fpage>24</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="doi">10.1016/j.trsl.2016.04.007</pub-id>
<pub-id pub-id-type="other">2-s2.0-84971668277</pub-id>
<pub-id pub-id-type="pmid">27187743</pub-id>
</element-citation>
</ref>
<ref id="B117">
<label>117</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>W. H. W.</given-names>
</name>
<name>
<surname>Kitai</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Hazen</surname>
<given-names>S. L.</given-names>
</name>
</person-group>
<article-title>Gut microbiota in cardiovascular health and disease</article-title>
<source/>
<italic toggle="yes">Circulation Research</italic>
<year>2017</year>
<volume>120</volume>
<issue>7</issue>
<fpage>1183</fpage>
<lpage>1196</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCRESAHA.117.309715</pub-id>
<pub-id pub-id-type="other">2-s2.0-85016760436</pub-id>
<pub-id pub-id-type="pmid">28360349</pub-id>
</element-citation>
</ref>
<ref id="B118">
<label>118</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bäckhed</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Sonnenburg</surname>
<given-names>J. L.</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J. I.</given-names>
</name>
</person-group>
<article-title>Host-bacterial mutualism in the human intestine</article-title>
<source/>
<italic toggle="yes">Science</italic>
<year>2005</year>
<volume>307</volume>
<issue>5717</issue>
<fpage>1915</fpage>
<lpage>1920</lpage>
<pub-id pub-id-type="doi">10.1126/science.1104816</pub-id>
<pub-id pub-id-type="other">2-s2.0-15544369658</pub-id>
<pub-id pub-id-type="pmid">15790844</pub-id>
</element-citation>
</ref>
<ref id="B119">
<label>119</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mazmanian</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C. H.</given-names>
</name>
<name>
<surname>Tzianabos</surname>
<given-names>A. O.</given-names>
</name>
<name>
<surname>Kasper</surname>
<given-names>D. L.</given-names>
</name>
</person-group>
<article-title>An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system</article-title>
<source/>
<italic toggle="yes">Cell</italic>
<year>2005</year>
<volume>122</volume>
<issue>1</issue>
<fpage>107</fpage>
<lpage>118</lpage>
<pub-id pub-id-type="doi">10.1016/j.cell.2005.05.007</pub-id>
<pub-id pub-id-type="other">2-s2.0-22144490199</pub-id>
<pub-id pub-id-type="pmid">16009137</pub-id>
</element-citation>
</ref>
<ref id="B120">
<label>120</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Symbiotic gut microbes modulate human metabolic phenotypes</article-title>
<source/>
<italic toggle="yes">Proceedings of the National Academy of Sciences of the United States of America</italic>
<year>2008</year>
<volume>105</volume>
<issue>6</issue>
<fpage>2117</fpage>
<lpage>2122</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0712038105</pub-id>
<pub-id pub-id-type="other">2-s2.0-41149099000</pub-id>
<pub-id pub-id-type="pmid">18252821</pub-id>
</element-citation>
</ref>
<ref id="B121">
<label>121</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alfano</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Canducci</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Nebuloni</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Clementi</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Montorsi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Salonia</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>The interplay of extracellular matrix and microbiome in urothelial bladder cancer</article-title>
<source/>
<italic toggle="yes">Nature Reviews Urology</italic>
<year>2016</year>
<volume>13</volume>
<issue>2</issue>
<fpage>77</fpage>
<lpage>90</lpage>
<pub-id pub-id-type="doi">10.1038/nrurol.2015.292</pub-id>
<pub-id pub-id-type="other">2-s2.0-84957432532</pub-id>
<pub-id pub-id-type="pmid">26666363</pub-id>
</element-citation>
</ref>
<ref id="B122">
<label>122</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turnbaugh</surname>
<given-names>P. J.</given-names>
</name>
<name>
<surname>Ley</surname>
<given-names>R. E.</given-names>
</name>
<name>
<surname>Mahowald</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Magrini</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Mardis</surname>
<given-names>E. R.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>J. I.</given-names>
</name>
</person-group>
<article-title>An obesity-associated gut microbiome with increased capacity for energy harvest</article-title>
<source/>
<italic toggle="yes">Nature</italic>
<year>2006</year>
<volume>444</volume>
<issue>7122</issue>
<fpage>1027</fpage>
<lpage>1031</lpage>
<pub-id pub-id-type="doi">10.1038/nature05414</pub-id>
<pub-id pub-id-type="other">2-s2.0-33845874101</pub-id>
<pub-id pub-id-type="pmid">17183312</pub-id>
</element-citation>
</ref>
<ref id="B123">
<label>123</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hildebrandt</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Sherrill–Mix</surname>
<given-names>S. A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-fat diet determines the composition of the murine gut microbiome independently of obesity</article-title>
<source/>
<italic toggle="yes">Gastroenterology</italic>
<year>2009</year>
<volume>137</volume>
<issue>5</issue>
<fpage>1716</fpage>
<lpage>1724.e2</lpage>
<pub-id pub-id-type="doi">10.1053/j.gastro.2009.08.042</pub-id>
<pub-id pub-id-type="other">2-s2.0-70350110294</pub-id>
<pub-id pub-id-type="pmid">19706296</pub-id>
</element-citation>
</ref>
<ref id="B124">
<label>124</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parks</surname>
<given-names>B. W.</given-names>
</name>
<name>
<surname>Nam</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Org</surname>
<given-names>E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genetic control of obesity and gut microbiota composition in response to high-fat, high-sucrose diet in mice</article-title>
<source/>
<italic toggle="yes">Cell Metabolism</italic>
<year>2013</year>
<volume>17</volume>
<issue>1</issue>
<fpage>141</fpage>
<lpage>152</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2012.12.007</pub-id>
<pub-id pub-id-type="other">2-s2.0-84872156123</pub-id>
<pub-id pub-id-type="pmid">23312289</pub-id>
</element-citation>
</ref>
<ref id="B125">
<label>125</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Di Luccia</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Crescenzo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mazzoli</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Rescue of fructose-induced metabolic syndrome by antibiotics or faecal transplantation in a rat model of obesity</article-title>
<source/>
<italic toggle="yes">PLoS One</italic>
<year>2015</year>
<volume>10</volume>
<issue>8, article e0134893</issue>
<pub-id pub-id-type="doi">10.1371/journal.pone.0134893</pub-id>
<pub-id pub-id-type="other">2-s2.0-84941975667</pub-id>
<pub-id pub-id-type="pmid">26244577</pub-id>
</element-citation>
</ref>
<ref id="B126">
<label>126</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>G. D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hoffmann</surname>
<given-names>C.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Linking long-term dietary patterns with gut microbial enterotypes</article-title>
<source/>
<italic toggle="yes">Science</italic>
<year>2011</year>
<volume>334</volume>
<issue>6052</issue>
<fpage>105</fpage>
<lpage>108</lpage>
<pub-id pub-id-type="doi">10.1126/science.1208344</pub-id>
<pub-id pub-id-type="other">2-s2.0-80053618114</pub-id>
<pub-id pub-id-type="pmid">21885731</pub-id>
</element-citation>
</ref>
<ref id="B127">
<label>127</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>David</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Maurice</surname>
<given-names>C. F.</given-names>
</name>
<name>
<surname>Carmody</surname>
<given-names>R. N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Diet rapidly and reproducibly alters the human gut microbiome</article-title>
<source/>
<italic toggle="yes">Nature</italic>
<year>2014</year>
<volume>505</volume>
<issue>7484</issue>
<fpage>559</fpage>
<lpage>563</lpage>
<pub-id pub-id-type="doi">10.1038/nature12820</pub-id>
<pub-id pub-id-type="other">2-s2.0-84892828465</pub-id>
<pub-id pub-id-type="pmid">24336217</pub-id>
</element-citation>
</ref>
<ref id="B128">
<label>128</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fava</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Gitau</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Griffin</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Gibson</surname>
<given-names>G. R.</given-names>
</name>
<name>
<surname>Tuohy</surname>
<given-names>K. M.</given-names>
</name>
<name>
<surname>Lovegrove</surname>
<given-names>J. A.</given-names>
</name>
</person-group>
<article-title>The type and quantity of dietary fat and carbohydrate alter faecal microbiome and short-chain fatty acid excretion in a metabolic syndrome ‘at-risk’ population</article-title>
<source/>
<italic toggle="yes">International Journal of Obesity</italic>
<year>2013</year>
<volume>37</volume>
<issue>2</issue>
<fpage>216</fpage>
<lpage>223</lpage>
<pub-id pub-id-type="doi">10.1038/ijo.2012.33</pub-id>
<pub-id pub-id-type="other">2-s2.0-84873724959</pub-id>
<pub-id pub-id-type="pmid">22410962</pub-id>
</element-citation>
</ref>
<ref id="B129">
<label>129</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Elliott</surname>
<given-names>S. S.</given-names>
</name>
<name>
<surname>Keim</surname>
<given-names>N. L.</given-names>
</name>
<name>
<surname>Stern</surname>
<given-names>J. S.</given-names>
</name>
<name>
<surname>Teff</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Havel</surname>
<given-names>P. J.</given-names>
</name>
</person-group>
<article-title>Fructose, weight gain, and the insulin resistance syndrome</article-title>
<source/>
<italic toggle="yes">The American Journal of Clinical Nutrition</italic>
<year>2002</year>
<volume>76</volume>
<issue>5</issue>
<fpage>911</fpage>
<lpage>922</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/76.5.911</pub-id>
<pub-id pub-id-type="pmid">12399260</pub-id>
</element-citation>
</ref>
<ref id="B130">
<label>130</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bray</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Nielsen</surname>
<given-names>S. J.</given-names>
</name>
<name>
<surname>Popkin</surname>
<given-names>B. M.</given-names>
</name>
</person-group>
<article-title>Consumption of highfructose corn syrup in beverages may play a role in the epidemic of obesity</article-title>
<source/>
<italic toggle="yes">The American Journal of Clinical Nutrition</italic>
<year>2004</year>
<volume>79</volume>
<issue>4</issue>
<fpage>537</fpage>
<lpage>543</lpage>
<pub-id pub-id-type="doi">10.1093/ajcn/79.4.537</pub-id>
<pub-id pub-id-type="pmid">15051594</pub-id>
</element-citation>
</ref>
<ref id="B131">
<label>131</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tappy</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Le</surname>
<given-names>K. A.</given-names>
</name>
</person-group>
<article-title>Metabolic effects of fructose and the worldwide increase in obesity</article-title>
<source/>
<italic toggle="yes">Physiological Reviews</italic>
<year>2010</year>
<volume>90</volume>
<issue>1</issue>
<fpage>23</fpage>
<lpage>46</lpage>
<pub-id pub-id-type="doi">10.1152/physrev.00019.2009</pub-id>
<pub-id pub-id-type="other">2-s2.0-75149166672</pub-id>
<pub-id pub-id-type="pmid">20086073</pub-id>
</element-citation>
</ref>
<ref id="B132">
<label>132</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dekker</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Rutledge</surname>
<given-names>A. C.</given-names>
</name>
<name>
<surname>Adeli</surname>
<given-names>K.</given-names>
</name>
</person-group>
<article-title>Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome</article-title>
<source/>
<italic toggle="yes">American Journal of Physiology-Endocrinology and Metabolism</italic>
<year>2010</year>
<volume>299</volume>
<issue>5</issue>
<fpage>E685</fpage>
<lpage>E694</lpage>
<pub-id pub-id-type="doi">10.1152/ajpendo.00283.2010</pub-id>
<pub-id pub-id-type="other">2-s2.0-78349283092</pub-id>
<pub-id pub-id-type="pmid">20823452</pub-id>
</element-citation>
</ref>
<ref id="B133">
<label>133</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kelishadi</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mansourian</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Heidari-Beni</surname>
<given-names>M.</given-names>
</name>
</person-group>
<article-title>Association of fructose consumption and components of metabolic syndrome in human studies: a systematic review and metaanalysis</article-title>
<source/>
<italic toggle="yes">Nutrition</italic>
<year>2014</year>
<volume>30</volume>
<issue>5</issue>
<fpage>503</fpage>
<lpage>510</lpage>
<pub-id pub-id-type="doi">10.1016/j.nut.2013.08.014</pub-id>
<pub-id pub-id-type="other">2-s2.0-84897106960</pub-id>
<pub-id pub-id-type="pmid">24698343</pub-id>
</element-citation>
</ref>
<ref id="B134">
<label>134</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guasch‐Ferré</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hu</surname>
<given-names>F. B.</given-names>
</name>
<name>
<surname>Ruiz‐Canela</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Plasma metabolites from choline pathway and risk of cardiovascular disease in the PREDIMED (Prevention With Mediterranean Diet) Study</article-title>
<source/>
<italic toggle="yes">Journal of the American Heart Association</italic>
<year>2017</year>
<volume>6</volume>
<issue>11, article e006524</issue>
<pub-id pub-id-type="doi">10.1161/jaha.117.006524</pub-id>
<pub-id pub-id-type="other">2-s2.0-85034779007</pub-id>
<pub-id pub-id-type="pmid">29080862</pub-id>
</element-citation>
</ref>
<ref id="B135">
<label>135</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klinder</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shen</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Heppel</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Lovegrove</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Rowland</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Tuohy</surname>
<given-names>K. M.</given-names>
</name>
</person-group>
<article-title>Impact of increasing fruit and vegetables and flavonoid intake on the human gut microbiota</article-title>
<source/>
<italic toggle="yes">Food &amp; Function</italic>
<year>2016</year>
<volume>7</volume>
<issue>4</issue>
<fpage>1788</fpage>
<lpage>1796</lpage>
<pub-id pub-id-type="doi">10.1039/C5FO01096A</pub-id>
<pub-id pub-id-type="other">2-s2.0-84966355957</pub-id>
<pub-id pub-id-type="pmid">26757793</pub-id>
</element-citation>
</ref>
<ref id="B136">
<label>136</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fava</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Rizzetto</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tuohy</surname>
<given-names>K. M.</given-names>
</name>
</person-group>
<article-title>Gut microbiota and health: connecting actors across the metabolic system</article-title>
<source/>
<italic toggle="yes">Proceedings of the Nutrition Society</italic>
<year>2018</year>
<volume>18</volume>
<fpage>1</fpage>
<lpage>12</lpage>
<pub-id pub-id-type="doi">10.1017/s0029665118002719</pub-id>
<pub-id pub-id-type="pmid">30561288</pub-id>
</element-citation>
</ref>
<ref id="B137">
<label>137</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chong</surname>
<given-names>M. F.</given-names>
</name>
<name>
<surname>George</surname>
<given-names>T. W.</given-names>
</name>
<name>
<surname>Alimbetov</surname>
<given-names>D.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Impact of the quantity and flavonoid content of fruits and vegetables on markers of intake in adults with an increased risk of cardiovascular disease: the FLAVURS trial</article-title>
<source/>
<italic toggle="yes">European Journal of Nutrition</italic>
<year>2013</year>
<volume>52</volume>
<issue>1</issue>
<fpage>361</fpage>
<lpage>378</lpage>
<pub-id pub-id-type="doi">10.1007/s00394-012-0343-3</pub-id>
<pub-id pub-id-type="other">2-s2.0-84872681333</pub-id>
<pub-id pub-id-type="pmid">22476876</pub-id>
</element-citation>
</ref>
<ref id="B138">
<label>138</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Macready</surname>
<given-names>A. L.</given-names>
</name>
<name>
<surname>George</surname>
<given-names>T. W.</given-names>
</name>
<name>
<surname>Chong</surname>
<given-names>M. F.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Flavonoid-rich fruit and vegetables improve microvascular reactivity and inflammatory status in men at risk of cardiovascular disease FLAVURS: a randomized controlled trial</article-title>
<source/>
<italic toggle="yes">The American Journal of Clinical Nutrition</italic>
<year>2014</year>
<volume>99</volume>
<issue>3</issue>
<fpage>479</fpage>
<lpage>489</lpage>
<pub-id pub-id-type="doi">10.3945/ajcn.113.074237</pub-id>
<pub-id pub-id-type="other">2-s2.0-84896874427</pub-id>
<pub-id pub-id-type="pmid">24452238</pub-id>
</element-citation>
</ref>
<ref id="B139">
<label>139</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hill</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Guarner</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Reid</surname>
<given-names>G.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic</article-title>
<source/>
<italic toggle="yes">Nature Reviews Gastroenterology &amp; Hepatology</italic>
<year>2014</year>
<volume>11</volume>
<issue>8</issue>
<fpage>506</fpage>
<lpage>514</lpage>
<pub-id pub-id-type="doi">10.1038/nrgastro.2014.66</pub-id>
<pub-id pub-id-type="other">2-s2.0-84905675648</pub-id>
<pub-id pub-id-type="pmid">24912386</pub-id>
</element-citation>
</ref>
<ref id="B140">
<label>140</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibson</surname>
<given-names>G. R.</given-names>
</name>
<name>
<surname>Hutkins</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>M. E.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics</article-title>
<source/>
<italic toggle="yes">Nature Reviews Gastroenterology &amp; Hepatology</italic>
<year>2017</year>
<volume>14</volume>
<issue>8</issue>
<fpage>491</fpage>
<lpage>502</lpage>
<pub-id pub-id-type="doi">10.1038/nrgastro.2017.75</pub-id>
<pub-id pub-id-type="other">2-s2.0-85027283029</pub-id>
<pub-id pub-id-type="pmid">28611480</pub-id>
</element-citation>
</ref>
<ref id="B141">
<label>141</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Amirkhizi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Siassi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Djalali</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Shahraki</surname>
<given-names>S. H.</given-names>
</name>
</person-group>
<article-title>Impaired enzymatic antioxidant defense in erythrocytes of women with general and abdominal obesity</article-title>
<source/>
<italic toggle="yes">Obesity Research &amp; Clinical Practice</italic>
<year>2014</year>
<volume>8</volume>
<issue>1</issue>
<fpage>e26</fpage>
<lpage>e34</lpage>
<pub-id pub-id-type="doi">10.1016/j.orcp.2012.07.004</pub-id>
<pub-id pub-id-type="other">2-s2.0-84894068766</pub-id>
<pub-id pub-id-type="pmid">24548574</pub-id>
</element-citation>
</ref>
<ref id="B142">
<label>142</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gyawali</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>R. S.</given-names>
</name>
</person-group>
<article-title>Association of altered hemorheology with oxidative stress and inflammation in metabolic syndrome</article-title>
<source/>
<italic toggle="yes">Redox Report</italic>
<year>2015</year>
<volume>20</volume>
<issue>3</issue>
<fpage>139</fpage>
<lpage>144</lpage>
<pub-id pub-id-type="doi">10.1179/1351000214Y.0000000120</pub-id>
<pub-id pub-id-type="other">2-s2.0-84926305795</pub-id>
<pub-id pub-id-type="pmid">25494675</pub-id>
</element-citation>
</ref>
<ref id="B143">
<label>143</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sablina</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Budanov</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Ilyinskaya</surname>
<given-names>G. V.</given-names>
</name>
<name>
<surname>Agapova</surname>
<given-names>L. S.</given-names>
</name>
<name>
<surname>Kravchenko</surname>
<given-names>J. E.</given-names>
</name>
<name>
<surname>Chumakov</surname>
<given-names>P. M.</given-names>
</name>
</person-group>
<article-title>The antioxidant function of the p53 tumor suppressor</article-title>
<source/>
<italic toggle="yes">Nature Medicine</italic>
<year>2005</year>
<volume>11</volume>
<issue>12</issue>
<fpage>1306</fpage>
<lpage>1313</lpage>
<pub-id pub-id-type="doi">10.1038/nm1320</pub-id>
<pub-id pub-id-type="other">2-s2.0-28644447272</pub-id>
<pub-id pub-id-type="pmid">16286925</pub-id>
</element-citation>
</ref>
<ref id="B144">
<label>144</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jialal</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Devaraj</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Adams-Huet</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Kaur</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Increased cellular and circulating biomarkers of oxidative stress in nascent metabolic syndrome</article-title>
<source/>
<italic toggle="yes">Journal of Clinical Endocrinology and Metabolism</italic>
<year>2012</year>
<volume>97</volume>
<issue>10</issue>
<fpage>E1844</fpage>
<lpage>E1850</lpage>
<pub-id pub-id-type="doi">10.1210/jc.2012-2498</pub-id>
<pub-id pub-id-type="other">2-s2.0-84867271268</pub-id>
<pub-id pub-id-type="pmid">22872691</pub-id>
</element-citation>
</ref>
<ref id="B145">
<label>145</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Siow</surname>
<given-names>R. C. M.</given-names>
</name>
<name>
<surname>Mann</surname>
<given-names>G. E.</given-names>
</name>
</person-group>
<article-title>Impaired redox signaling and antioxidant gene expression in endothelial cells in diabetes: a role for mitochondria and the nuclear factor-E2-related factor 2-Kelch-like ECH-associated protein 1 defense pathway</article-title>
<source/>
<italic toggle="yes">Antioxidants &amp; Redox Signaling</italic>
<year>2011</year>
<volume>14</volume>
<issue>3</issue>
<fpage>469</fpage>
<lpage>487</lpage>
<pub-id pub-id-type="doi">10.1089/ars.2010.3283</pub-id>
<pub-id pub-id-type="other">2-s2.0-78650913154</pub-id>
<pub-id pub-id-type="pmid">20524845</pub-id>
</element-citation>
</ref>
<ref id="B146">
<label>146</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aouacheri</surname>
<given-names>O.</given-names>
</name>
<name>
<surname>Saka</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Krim</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Messaadia</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Maidi</surname>
<given-names>I.</given-names>
</name>
</person-group>
<article-title>The investigation of the oxidative stress-related parameters in type 2 diabetes mellitus</article-title>
<source/>
<italic toggle="yes">Canadian Journal of Diabetes</italic>
<year>2015</year>
<volume>39</volume>
<issue>1</issue>
<fpage>44</fpage>
<lpage>49</lpage>
<pub-id pub-id-type="doi">10.1016/j.jcjd.2014.03.002</pub-id>
<pub-id pub-id-type="other">2-s2.0-84921354808</pub-id>
<pub-id pub-id-type="pmid">25065473</pub-id>
</element-citation>
</ref>
<ref id="B147">
<label>147</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tinkov</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Bjørklund</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Skalny</surname>
<given-names>A. V.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker?</article-title>
<source/>
<italic toggle="yes">Cellular and Molecular Life Sciences</italic>
<year>2018</year>
<volume>75</volume>
<issue>9</issue>
<fpage>1567</fpage>
<lpage>1586</lpage>
<pub-id pub-id-type="doi">10.1007/s00018-018-2745-8</pub-id>
<pub-id pub-id-type="other">2-s2.0-85040332530</pub-id>
<pub-id pub-id-type="pmid">29327078</pub-id>
</element-citation>
</ref>
<ref id="B148">
<label>148</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jankovic</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Korac</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Srdic-Galic</surname>
<given-names>B.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Differences in the redox status of human visceral and subcutaneous adipose tissues--relationships to obesity and metabolic risk</article-title>
<source/>
<italic toggle="yes">Metabolism</italic>
<year>2014</year>
<volume>63</volume>
<issue>5</issue>
<fpage>661</fpage>
<lpage>671</lpage>
<pub-id pub-id-type="doi">10.1016/j.metabol.2014.01.009</pub-id>
<pub-id pub-id-type="other">2-s2.0-84899430462</pub-id>
<pub-id pub-id-type="pmid">24582138</pub-id>
</element-citation>
</ref>
<ref id="B149">
<label>149</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iglesia</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Mouratidou</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>González-Gross</surname>
<given-names>M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Foods contributing to vitamin B<sub>6</sub>, folate, and vitamin B<sub>12</sub> intakes and biomarkers status in European adolescents: the HELENA study</article-title>
<source/>
<italic toggle="yes">European Journal of Nutrition</italic>
<year>2017</year>
<volume>56</volume>
<issue>4</issue>
<fpage>1767</fpage>
<lpage>1782</lpage>
<pub-id pub-id-type="doi">10.1007/s00394-016-1221-1</pub-id>
<pub-id pub-id-type="other">2-s2.0-84975110985</pub-id>
<pub-id pub-id-type="pmid">27312567</pub-id>
</element-citation>
</ref>
<ref id="B150">
<label>150</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Abete</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Astrup</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Martínez</surname>
<given-names>J. A.</given-names>
</name>
<name>
<surname>Thorsdottir</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Zulet</surname>
<given-names>M. A.</given-names>
</name>
</person-group>
<article-title>Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance</article-title>
<source/>
<italic toggle="yes">Nutrition Reviews</italic>
<year>2010</year>
<volume>68</volume>
<issue>4</issue>
<fpage>214</fpage>
<lpage>231</lpage>
<pub-id pub-id-type="doi">10.1111/j.1753-4887.2010.00280.x</pub-id>
<pub-id pub-id-type="other">2-s2.0-77954594020</pub-id>
<pub-id pub-id-type="pmid">20416018</pub-id>
</element-citation>
</ref>
<ref id="B151">
<label>151</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zamora-Ros</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Serafini</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Estruch</surname>
<given-names>R.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mediterranean diet and non enzymatic antioxidant capacity in the PREDIMED study: evidence for a mechanism of antioxidant tuning</article-title>
<source/>
<italic toggle="yes">Nutrition, Metabolism &amp; Cardiovascular Diseases</italic>
<year>2013</year>
<volume>23</volume>
<issue>12</issue>
<fpage>1167</fpage>
<lpage>1174</lpage>
<pub-id pub-id-type="doi">10.1016/j.numecd.2012.12.008</pub-id>
<pub-id pub-id-type="other">2-s2.0-84888823654</pub-id>
</element-citation>
</ref>
<ref id="B152">
<label>152</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gregório</surname>
<given-names>B. M.</given-names>
</name>
<name>
<surname>De Souza</surname>
<given-names>D. B.</given-names>
</name>
<name>
<surname>de Morais Nascimento</surname>
<given-names>F. A.</given-names>
</name>
<name>
<surname>Matta</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Fernandes-Santos</surname>
<given-names>C.</given-names>
</name>
</person-group>
<article-title>The potential role of antioxidants in metabolic syndrome</article-title>
<source/>
<italic toggle="yes">Current Pharmaceutical Design</italic>
<year>2016</year>
<volume>22</volume>
<issue>7</issue>
<fpage>859</fpage>
<lpage>869</lpage>
<pub-id pub-id-type="doi">10.2174/1381612822666151209152352</pub-id>
<pub-id pub-id-type="pmid">26648468</pub-id>
</element-citation>
</ref>
<ref id="B153">
<label>153</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>H.</given-names>
</name>
</person-group>
<article-title>Effects of vitamin E on plasma lipid status and oxidative stress in Chinese women with metabolic syndrome</article-title>
<source/>
<italic toggle="yes">International Journal for Vitamin and Nutrition Research</italic>
<year>2010</year>
<volume>80</volume>
<issue>3</issue>
<fpage>178</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="doi">10.1024/0300-9831/a000015</pub-id>
<pub-id pub-id-type="other">2-s2.0-78751633513</pub-id>
<pub-id pub-id-type="pmid">21234859</pub-id>
</element-citation>
</ref>
<ref id="B154">
<label>154</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rafighi</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Shiva</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Arab</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Mohd Yousof</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Association of dietary vitamin C and e intake and antioxidant enzymes in type 2 diabetes mellitus patients</article-title>
<source/>
<italic toggle="yes">Global Journal of Health Science</italic>
<year>2013</year>
<volume>5</volume>
<issue>3</issue>
<fpage>183</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="doi">10.5539/gjhs.v5n3p183</pub-id>
<pub-id pub-id-type="other">2-s2.0-84880638031</pub-id>
<pub-id pub-id-type="pmid">23618488</pub-id>
</element-citation>
</ref>
<ref id="B155">
<label>155</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lavie</surname>
<given-names>C. J.</given-names>
</name>
<name>
<surname>Milani</surname>
<given-names>J. N.</given-names>
</name>
</person-group>
<article-title>Do antioxidant vitamins ameliorate the beneficial effects of exercise training on insulin sensitivity?</article-title>
<source/>
<italic toggle="yes">Journal of Cardiopulmonary Rehabilitation and Prevention</italic>
<year>2011</year>
<volume>31</volume>
<issue>4</issue>
<fpage>211</fpage>
<lpage>216</lpage>
<pub-id pub-id-type="doi">10.1097/HCR.0b013e318211e3d8</pub-id>
<pub-id pub-id-type="other">2-s2.0-79960835978</pub-id>
<pub-id pub-id-type="pmid">21427602</pub-id>
</element-citation>
</ref>
<ref id="B156">
<label>156</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Das</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>D.</given-names>
</name>
</person-group>
<article-title>Anti-inflammatory responses of resveratrol</article-title>
<source/>
<italic toggle="yes">Inflammation &amp; Allergy-Drug Targets</italic>
<year>2007</year>
<volume>6</volume>
<issue>3</issue>
<fpage>168</fpage>
<lpage>173</lpage>
<pub-id pub-id-type="doi">10.2174/187152807781696464</pub-id>
<pub-id pub-id-type="other">2-s2.0-34648830916</pub-id>
<pub-id pub-id-type="pmid">17897053</pub-id>
</element-citation>
</ref>
<ref id="B157">
<label>157</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Siwik</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Luptak</surname>
<given-names>I.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice</article-title>
<source/>
<italic toggle="yes">Circulation</italic>
<year>2012</year>
<volume>125</volume>
<issue>14</issue>
<fpage>1757</fpage>
<lpage>1764</lpage>
<pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.111.067801</pub-id>
<pub-id pub-id-type="other">2-s2.0-84859524897</pub-id>
<pub-id pub-id-type="pmid">22388319</pub-id>
</element-citation>
</ref>
<ref id="B158">
<label>158</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robich</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Osipov</surname>
<given-names>R. M.</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>L. M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Resveratrol modifies risk factors for coronary artery disease in swine with metabolic syndrome and myocardial ischemia</article-title>
<source/>
<italic toggle="yes">European Journal of Pharmacology</italic>
<year>2011</year>
<volume>664</volume>
<issue>1-3</issue>
<fpage>45</fpage>
<lpage>53</lpage>
<pub-id pub-id-type="doi">10.1016/j.ejphar.2011.04.059</pub-id>
<pub-id pub-id-type="other">2-s2.0-79957895283</pub-id>
<pub-id pub-id-type="pmid">21575630</pub-id>
</element-citation>
</ref>
<ref id="B159">
<label>159</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bagul</surname>
<given-names>P. K.</given-names>
</name>
<name>
<surname>Middela</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Matapally</surname>
<given-names>S.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Attenuation of insulin resistance, metabolic syndrome and hepatic oxidative stress by resveratrol in fructose-fed rats</article-title>
<source/>
<italic toggle="yes">Pharmacological Research</italic>
<year>2012</year>
<volume>66</volume>
<issue>3</issue>
<fpage>260</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="doi">10.1016/j.phrs.2012.05.003</pub-id>
<pub-id pub-id-type="other">2-s2.0-84864277111</pub-id>
<pub-id pub-id-type="pmid">22627169</pub-id>
</element-citation>
</ref>
<ref id="B160">
<label>160</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Timmers</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Konings</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Bilet</surname>
<given-names>L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans</article-title>
<source/>
<italic toggle="yes">Cell Metabolism</italic>
<year>2011</year>
<volume>14</volume>
<issue>5</issue>
<fpage>612</fpage>
<lpage>622</lpage>
<pub-id pub-id-type="doi">10.1016/j.cmet.2011.10.002</pub-id>
<pub-id pub-id-type="other">2-s2.0-80455143206</pub-id>
<pub-id pub-id-type="pmid">22055504</pub-id>
</element-citation>
</ref>
<ref id="B161">
<label>161</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hermans</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Van der Auwera</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Breynaert</surname>
<given-names>A.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A red yeast rice-olive extract supplement reduces biomarkers of oxidative stress, OxLDL and Lp-PLA<sub>2</sub>, in subjects with metabolic syndrome: a randomised, double-blind, placebo-controlled trial</article-title>
<source/>
<italic toggle="yes">Trials</italic>
<year>2017</year>
<volume>18</volume>
<issue>1</issue>
<fpage>p. 302</fpage>
<pub-id pub-id-type="doi">10.1186/s13063-017-2058-5</pub-id>
<pub-id pub-id-type="other">2-s2.0-85021639641</pub-id>
<pub-id pub-id-type="pmid">28673363</pub-id>
</element-citation>
</ref>
<ref id="B162">
<label>162</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Egert</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Bosy-Westphal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Seiberl</surname>
<given-names>J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: a double-blinded, placebo-controlled cross-over study</article-title>
<source/>
<italic toggle="yes">British Journal of Nutrition</italic>
<year>2009</year>
<volume>102</volume>
<issue>7</issue>
<fpage>1065</fpage>
<lpage>1674</lpage>
<pub-id pub-id-type="doi">10.1017/S0007114509359127</pub-id>
<pub-id pub-id-type="other">2-s2.0-73749083955</pub-id>
<pub-id pub-id-type="pmid">19402938</pub-id>
</element-citation>
</ref>
<ref id="B163">
<label>163</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panchal</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Poudyal</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Brown</surname>
<given-names>L.</given-names>
</name>
</person-group>
<article-title>Quercetin ameliorates cardiovascular, hepatic, and metabolic changes in diet-induced metabolic syndrome in rats</article-title>
<source/>
<italic toggle="yes">The Journal of Nutrition</italic>
<year>2012</year>
<volume>142</volume>
<issue>6</issue>
<fpage>1026</fpage>
<lpage>1032</lpage>
<pub-id pub-id-type="doi">10.3945/jn.111.157263</pub-id>
<pub-id pub-id-type="other">2-s2.0-84863550183</pub-id>
<pub-id pub-id-type="pmid">22535755</pub-id>
</element-citation>
</ref>
<ref id="B164">
<label>164</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bahadoran</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Mirmiran</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Azizi</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Dietary polyphenols as potential nutraceuticals in management of diabetes: a review</article-title>
<source/>
<italic toggle="yes">Journal of Diabetes &amp; Metabolic Disorders</italic>
<year>2013</year>
<volume>12</volume>
<issue>1</issue>
<fpage>p. 43</fpage>
<pub-id pub-id-type="doi">10.1186/2251-6581-12-43</pub-id>
<pub-id pub-id-type="other">2-s2.0-84902083327</pub-id>
<pub-id pub-id-type="pmid">23938049</pub-id>
</element-citation>
</ref>
<ref id="B165">
<label>165</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bahadoran</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Mirmiran</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Azizi</surname>
<given-names>F.</given-names>
</name>
</person-group>
<article-title>Potential efficacy of broccoli sprouts as a unique supplement for management of type 2 diabetes and its complications</article-title>
<source/>
<italic toggle="yes">Journal of Medicinal Food</italic>
<year>2013</year>
<volume>16</volume>
<issue>5</issue>
<fpage>375</fpage>
<lpage>382</lpage>
<pub-id pub-id-type="doi">10.1089/jmf.2012.2559</pub-id>
<pub-id pub-id-type="other">2-s2.0-84877844387</pub-id>
<pub-id pub-id-type="pmid">23631497</pub-id>
</element-citation>
</ref>
<ref id="B166">
<label>166</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Panahi</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Hosseini</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Khalili</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Naimi</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Majeed</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Sahebkar</surname>
<given-names>A.</given-names>
</name>
</person-group>
<article-title>Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: a randomized controlled trial and an updated meta-analysis</article-title>
<source/>
<italic toggle="yes">Clinical Nutrition</italic>
<year>2015</year>
<volume>34</volume>
<issue>6</issue>
<fpage>1101</fpage>
<lpage>1108</lpage>
<pub-id pub-id-type="doi">10.1016/j.clnu.2014.12.019</pub-id>
<pub-id pub-id-type="other">2-s2.0-84921521472</pub-id>
<pub-id pub-id-type="pmid">25618800</pub-id>
</element-citation>
</ref>
<ref id="B167">
<label>167</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Subramanian</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kalyanaraman</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Migrino</surname>
<given-names>R.</given-names>
</name>
</person-group>
<article-title>Mitochondrially targeted antioxidants for the treatment of cardiovascular diseases</article-title>
<source/>
<italic toggle="yes">Recent Patents on Cardiovascular Drug Discovery</italic>
<year>2010</year>
<volume>5</volume>
<issue>1</issue>
<fpage>54</fpage>
<lpage>65</lpage>
<pub-id pub-id-type="doi">10.2174/157489010790192601</pub-id>
<pub-id pub-id-type="other">2-s2.0-77951143920</pub-id>
<pub-id pub-id-type="pmid">19807685</pub-id>
</element-citation>
</ref>
<ref id="B168">
<label>168</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Smith</surname>
<given-names>R. A.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>M. P.</given-names>
</name>
</person-group>
<article-title>Mitochondria-targeted antioxidants as therapies</article-title>
<source/>
<italic toggle="yes">Discovery Medicine</italic>
<year>2011</year>
<volume>11</volume>
<issue>57</issue>
<fpage>106</fpage>
<lpage>114</lpage>
<pub-id pub-id-type="pmid">21356165</pub-id>
</element-citation>
</ref>
<ref id="B169">
<label>169</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Houstis</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Rosen</surname>
<given-names>E. D.</given-names>
</name>
<name>
<surname>Lander</surname>
<given-names>E. S.</given-names>
</name>
</person-group>
<article-title>Reactive oxygen species have a causal role in multiple forms of insulin resistance</article-title>
<source/>
<italic toggle="yes">Nature</italic>
<year>2006</year>
<volume>440</volume>
<issue>7086</issue>
<fpage>944</fpage>
<lpage>948</lpage>
<pub-id pub-id-type="doi">10.1038/nature04634</pub-id>
<pub-id pub-id-type="other">2-s2.0-33645860825</pub-id>
<pub-id pub-id-type="pmid">16612386</pub-id>
</element-citation>
</ref>
<ref id="B170">
<label>170</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kocharian</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Shabanian</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Rafiei-Khorgami</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Kiani</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Heidari-Bateni</surname>
<given-names>G.</given-names>
</name>
</person-group>
<article-title>Coenzyme Q10 improves diastolic function in children with idiopathic dilated cardiomyopathy</article-title>
<source/>
<italic toggle="yes">Cardiology in the Young</italic>
<year>2009</year>
<volume>19</volume>
<issue>5</issue>
<fpage>501</fpage>
<lpage>506</lpage>
<pub-id pub-id-type="doi">10.1017/S1047951109990795</pub-id>
<pub-id pub-id-type="other">2-s2.0-75549084410</pub-id>
<pub-id pub-id-type="pmid">19703336</pub-id>
</element-citation>
</ref>
<ref id="B171">
<label>171</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Young</surname>
<given-names>J. M.</given-names>
</name>
<name>
<surname>Florkowski</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Molyneux</surname>
<given-names>S. L.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A randomized, double-blind, placebo-controlled crossover study of coenzyme q10 therapy in hypertensive patients with the metabolic syndrome</article-title>
<source/>
<italic toggle="yes">American Journal of Hypertension</italic>
<year>2012</year>
<volume>25</volume>
<issue>2</issue>
<fpage>261</fpage>
<lpage>270</lpage>
<pub-id pub-id-type="doi">10.1038/ajh.2011.209</pub-id>
<pub-id pub-id-type="other">2-s2.0-84856035599</pub-id>
<pub-id pub-id-type="pmid">22113168</pub-id>
</element-citation>
</ref>
<ref id="B172">
<label>172</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huynh</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Kiriazis</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Du</surname>
<given-names>X.-J.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Coenzyme Q<sub>10</sub> attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the <italic>db/db</italic> mouse model of type 2 diabetes</article-title>
<source/>
<italic toggle="yes">Diabetologia</italic>
<year>2012</year>
<volume>55</volume>
<issue>5</issue>
<fpage>1544</fpage>
<lpage>1553</lpage>
<pub-id pub-id-type="doi">10.1007/s00125-012-2495-3</pub-id>
<pub-id pub-id-type="other">2-s2.0-84862543941</pub-id>
<pub-id pub-id-type="pmid">22374176</pub-id>
</element-citation>
</ref>
<ref id="B173">
<label>173</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adlam</surname>
<given-names>V. J.</given-names>
</name>
<name>
<surname>Harrison</surname>
<given-names>J. C.</given-names>
</name>
<name>
<surname>Porteous</surname>
<given-names>C. M.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury</article-title>
<source/>
<italic toggle="yes">The FASEB Journal</italic>
<year>2005</year>
<volume>19</volume>
<issue>9</issue>
<fpage>1088</fpage>
<lpage>1095</lpage>
<pub-id pub-id-type="doi">10.1096/fj.05-3718com</pub-id>
<pub-id pub-id-type="other">2-s2.0-21744450416</pub-id>
<pub-id pub-id-type="pmid">15985532</pub-id>
</element-citation>
</ref>
<ref id="B174">
<label>174</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mercer</surname>
<given-names>J. R.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Figg</surname>
<given-names>N.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The mitochondria-targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM<sup>+/–</sup>/ApoE<sup>–/–</sup> mice</article-title>
<source/>
<italic toggle="yes">Free Radical Biology &amp; Medicine</italic>
<year>2012</year>
<volume>52</volume>
<issue>5</issue>
<fpage>841</fpage>
<lpage>849</lpage>
<pub-id pub-id-type="doi">10.1016/j.freeradbiomed.2011.11.026</pub-id>
<pub-id pub-id-type="other">2-s2.0-84856752588</pub-id>
<pub-id pub-id-type="pmid">22210379</pub-id>
</element-citation>
</ref>
<ref id="B175">
<label>175</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pung</surname>
<given-names>Y. F.</given-names>
</name>
<name>
<surname>Rocic</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>M. P.</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Resolution of mitochondrial oxidative stress rescues coronary collateral growth in Zucker obese fatty rats</article-title>
<source/>
<italic toggle="yes">Arteriosclerosis, Thrombosis, and Vascular Biology</italic>
<year>2012</year>
<volume>32</volume>
<issue>2</issue>
<fpage>325</fpage>
<lpage>334</lpage>
<pub-id pub-id-type="doi">10.1161/ATVBAHA.111.241802</pub-id>
<pub-id pub-id-type="other">2-s2.0-84862786348</pub-id>
<pub-id pub-id-type="pmid">22155454</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
<floats-group>
<fig id="fig1" orientation="portrait" position="float">
<label>Figure 1</label>
<caption>
<p>Oxidative stress and vascular implications in metabolic syndrome. Metabolic syndrome (MS) is characterized by risk factors having tissue oxidative stress (OS) as hallmark. Indeed, they are characterized by increased release and accumulation of proinflammatory mediators, such as free fatty acids (FFAs), high glucose levels, advanced glycation end-products (AGE), cytokines, and angiotensin II, as well as to the activation proinflammatory signals linked to the stimulation of protein kinase C (PKC) and polyol pathways. These conditions boost the increase in reactive oxygen (ROS) and nitrogen species (RNS) formation in tissues and in the vasculature through the activation of the related producing enzymes in the cytosol as well as in the mitochondria. The cytosolic enzymes include the different isoforms of NADPH oxidase (NOXs), nitric oxide synthase (NOS), cyclooxygenase (COX), xanthine oxidase, protein kinase C (PKC), uncoupled endothelial NOS (eNOS), and myeloperoxidase (MPO). Other potential sources of ROS and RNS are the oxidized RBCs (oxRBCs) and the increased NADH amounts. The former, forming in the vasculature under significant OS conditions, behave as prooxidant cells able also to release oxidant species. The latter, increased at expenses of NADPH under hyperglycemic conditions, can induce mitochondrial deregulation and ROS formation. Noteworthy for the MS-associated cardiovascular complications is the reduction in <sup>•</sup>NO bioavailability in the vasculature, notwithstanding the NOS upregulation. Indeed, the simultaneous increase in the concentration of <sup>•</sup>NO and O<sub>2</sub><sup><underline>•</underline></sup> allows these radicals to react fast generating the strong oxidant peroxynitrite (ONOO<sup>−</sup>), which deeply affects intracellular redox chemistry. The MS-associated diseases are also characterized by the downregulation of the antioxidant systems, including the depletion of GSH concentration and the decrease of the activity of the detoxifying enzymes, such as superoxide dismutase (SOD), catalase (Cat), glutathione peroxidase (Gpx), glutathione reductase (GR), and the couple constituted by thioredoxin (Trx) and thioredoxin reductase (TrxR). In addition, as in a vicious cycle, the increased ROS and RNS formation can further worse MS-related diseases by affecting in turn the intracellular pathway generating the proinflammatory mediators, as well as decrease the activity of the antioxidant systems. All these conditions result in the irreversible accumulation of oxidation products in proteins, lipids, and sugars, which allow the impairment of intracellular redox signaling and detrimentally affect vascular biology by promoting vascular inflammation, endothelial dysfunction, and vascular remodeling. These alterations underlie the typical MS-associated cardiovascular complications, such as coronary atherosclerotic disease, arterial hypertension, left ventricular hypertrophy, diastolic dysfunction, coronary microvascular disease, and autonomic dysfunction.</p>
</caption>
<graphic xlink:href="OMCL2019-8267234.001"></graphic>
</fig>
<fig id="fig2" orientation="portrait" position="float">
<label>Figure 2</label>
<caption>
<p>Mitochondria dynamics. Summary of major molecular events related to the mitochondria: apoptosis, mitophagy, and process of fusion/fission. In the apoptotic process, the function of BCL-2 family proteins in the control of integrity mitochondrial outer membrane is shown. In particular, the proapoptotic proteins BAX and BAK heterodimering open a channels, which allows the release of proteins such as the cytochrome-c, Smac/DIABLO, Endo G/AIF. These latter, in turn, led to caspase cascade activation, which induces the apoptotic modifications.</p>
</caption>
<graphic xlink:href="OMCL2019-8267234.002"></graphic>
</fig>
<fig id="fig3" orientation="portrait" position="float">
<label>Figure 3</label>
<caption>
<p>Main functions of bacteria in the gut. SCFAs: short-chain fatty acids.</p>
</caption>
<graphic xlink:href="OMCL2019-8267234.003"></graphic>
</fig>
<table-wrap id="tab1" orientation="portrait" position="float">
<label>Table 1</label>
<caption>
<p>Biomarkers of oxidative stress.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Biomarkers</th>
<th align="center" colspan="1" rowspan="1">Features</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">MDA (malondialdehyde)</td>
<td align="center" colspan="1" rowspan="1">Marker specific of omega-3 and omega-6 fatty acid peroxidation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">HNE (4-hydroxy-2 nonenal)</td>
<td align="center" colspan="1" rowspan="1">Marker of arachidonic and linoleic acid oxidation</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sulfenic acid (SOH)</td>
<td align="center" colspan="1" rowspan="1">Marker of cysteine residue oxidation in specific proteins or enzymes (reversible)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Sulfinic (-SOOH) and sulfonic (-SOOOH) acids</td>
<td align="center" colspan="1" rowspan="1">Marker of cysteine residue oxidation in specific proteins or enzymes (irreversible)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Protein nitrosylation</td>
<td align="center" colspan="1" rowspan="1">Marker of cysteine residue modification induced by RNS (reversible)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Nitrated proteins</td>
<td align="center" colspan="1" rowspan="1">Irreversible tyrosine residue modification induced by RNS</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Carbamylated proteins</td>
<td align="center" colspan="1" rowspan="1">Generated following the attack of the <sup>•</sup>OH radical to the residues of proline, lysine, and arginine</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Oxidized LDL</td>
<td align="center" colspan="1" rowspan="1">Generated by LDL oxidation with ROS, RNS, and carbon-centered radicals</td>
</tr>
</tbody>
</table>
</table-wrap>
</floats-group>
</article>
</pmc-articleset>